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Abstract: The African mosquito Anopheles gambiae is one of the major vectors for human 
malaria. Understanding its immune system may provide new means for disrupting the 
disease transmission. While the Drosophila melanogaster and Manduca sexta immune 
systems are well studied, most components of the mosquito system remain to be examined. 
Insect hemolymph contains important factors for humoral and cellular defense responses 
as well as immune signal transduction, including pattern recognition receptors, serine 
proteases, serpins, antimicrobial peptides. In the present study, we collected hemolymph 
samples from water- and E. coli-pricked A. gambiae larvae. The samples were separated 
on SDS-PAGE and subjected to LC-MS/MS analysis. The detected peptides were searched 
against A. gambiae proteins from VectorBase. We have identified a total of 1,756 proteins. 
Most of the abundant proteins contain putative signal peptides. Twenty-five most abundant 
proteins represent over half of the total protein amount, 109 proteins are up-regulated, 49 
are down-regulated, and 235 are considered to be defense-related. After examining the 
protein distribution in the gel slices, we found that more abundant proteins tend to exist in 
more of the slices. We also obtained evidence for proteolysis, post-translational 
modification, serpin-protease complex formation, and high Mr immune complex formation 
based on the distribution data. In addition to the proteomic study, we generated monoclonal 
antibodies against prophenoloxidases PPO2 and PPO7 and found that PPO2 is presented 
in the adult hemolymph. Lastly, we tried to knockdown PPO gene expression in female 
adults by injecting double-stranded RNA and examined their survival following an E. coli 
challenge. No significant difference was observed between the test and control groups.
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Vertebrates rely on their immune system to distinguish self from non-self and defend against 
invading pathogens. Immunity is divided into two types, innate and adaptive. Innate immunity is 
fast and can kill a broad spectrum of pathogens but lacks specificity. Adaptive immunity involves 
production of antibodies and T-cell receptors that recognize specific pathogens and development 
of immune cells that produce the specific proteins and, hence, is much slower. Only innate immune 
responses have been demonstrated to take place in most invertebrates including all insects. 
In insects, cuticle lining of body surfaces, digestive tract and trachea acts as a physical barrier 
for exogenous parasites and comprises the first line of defense (Tzou et al., 2000). If microbes cross 
this line, they may encounter humoral and cellular responses in the hemolymph (Jiravanichpaisal 
et al., 2006). Cellular responses involve phagocytosis, encapsulation, and nodule formation of 
pathogens by hemocytes (Lavine and Strand, 2002), while humoral responses are initiated upon 
recognition of pathogen-associated molecular patterns (PAMPs) by pathogen recognition receptors 
(PRRs) (Janeway and Medzhitov, 2002). The recognition activates a serine protease cascade in 
hemolymph, which ultimately leads to the generation of active phenoloxidase (PO) (Ragan et al., 
2009). PO catalyzes the melanotic encapsulation of invading parasites and mediates their clearance 
from the host. Apart from that, at least two signal transduction pathways exist in insects to mediate 
induced synthesis of antimicrobial peptides (AMPs). The Toll pathway, activated upon Gram-
positive bacterial and fungal infection, employs transcription factors Dif and Dorsal for AMP
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production (Leclerc and Reichhart, 2004; Pinheiro and Ellar, 2006). The IMD pathway, responsive 
to most Gram-negative bacterial infection, employs Relish to induce AMP production (Kurata, 
2010; Stoven et al., 2003) 
The genome sequence of A. gambiae was reported by Holt et al. (2002), and continuous 
efforts have been made to improve the gene annotation. Due to rapid development of proteomic 
methods, proteomic studies have been performed in A. gambiae as good complements to genomic 
and transcriptomic research. Dinglasan et al. (2009) found 12 peritrophins that contain chitin-
binding domains in the peritrophic matrix proteome. They form the matrix and protect mosquito 
from pathogens in the midgut. A majority of the proteins identified are related to immunity in the 
hemolymph proteome, including PPO2, CLIPB4 and CLIPA6, TEP15, SRPN2 and SRPN15 
(Paskewitz et al., 2005; Pinto et al., 2009). Others participate in iron or lipid metabolism, such as 
ferritin, apolipophorin III and MD2-related protein. In the proteome of saliva and salivary glands, 
D7-related proteins with pheromone/odorant binding domains were found to be highly abundant 
and gSGs were implicated in blood feeding (Francischetti et al., 2002; Kalume et al., 2005). Lefevre 
et al. (2007) found a wide range of molecules in the head proteome of A. gambiae which indicated 
an altered energy production in Plasmodium-infected mosquitoes. Phosphoglycerate mutase and 
tropomyosin in the head may be involved in behavioral manipulation. Lastly, two vitelline 
membrane proteins, seven chorion proteins and seven odorant binding proteins were identified in 
the eggshell proteome (Amenya et al., 2010). Enzymes involved in cross-linking and stabilizing 
the chorion, such as peroxidase, laccase 2, PPO9, thioredoxin, were also reported. 
Here we employ a new proteomic method and focus on the larval hemolymph proteins of A. 
gambiae. The objectives of my research are: 1) obtain a complete profile of proteins present in A. 
gambiae larval hemolymph; 2) analyze the distribution patterns of proteins in polyacrylamide gel 
and explore possible implications in protein function; 3) find out the expression profile and 





REVIEW OF LITERATURE 
 
Insect immune system 
The first line of insect antimicrobial defense is the cuticle or exoskeleton, which is composed 
of proteins embedded in chitin and serves as a physical barrier against pathogens in the environment 
(Tzou et al., 2000; Feldhaar and Gross, 2008). Ingestion of food can introduce microbes to the 
digestive tract. Midgut cells in many insects produce a peritrophic membrane to protect the gut wall 
from abrasive food. It is permeable to digestive enzymes and nutrients, but not to microbes. 
Some pathogens can bleach the barrier and enter hemocoel, where they will encounter the 
host cellular and humoral immune responses (Jiravanichpaisal et al., 2006). The cellular responses 
involve phagocytosis, nodule formation and encapsulation (Lavine and Strand, 2002). Phagocytosis 
is the engulfment of bacteria and fungi by plasmatocytes. When the size (or number) of microbes 
is too large to be engulfed, multicellular nodules are formed around the pathogens, which are often 
melanized subsequently. For parasites (e.g. nematodes) and parasitoids (e.g. wasp eggs), 
encapsulation by multi-layer hemocytes is employed to sequestrate them. 
Humoral responses are initiated by binding of free pathogen recognition receptors (PRRs) to 
pathogen associated molecular patterns (PAMPs). PAMPs, like peptidoglycan, β-1,3-glucan, 
lipopolysaccharide (LPS), and lipoteichoic acid (LTA), are structural features of many bacteria and 
fungi, which can be used to distinguish non-self from self by the host. Correspondingly, insects use 
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PRRs, such as peptidoglycan recognition proteins (PGRPs), β-1,3-glucan recognition proteins 
(βGRPs), Gram-negative bacteria binding proteins (GNBPs), and C-type lectins (CTLs) to identify 
those PAMPs (Janeway and Medzhitov 2002). Binding of PRRs to PAMPs activates a serine 
protease cascade in the insect hemolymph, which ultimately leads to the activation of 
prophenoloxidase (PPO) (Ragan et al., 2009). Active PO is a key enzyme for melanization. The 
protease system is regulated by serine protease inhibitors of the serpin superfamily (Kanost et al., 
2004). 
Furthermore, recognition of the PAMPs by PRRs directly or indirectly activates two immune 
signal transduction pathways, which up-regulates the expression of distinct but overlapping sets of 
antimicrobial peptide (AMP) genes in Drosophila. One is the Toll pathway, which responds to 
Gram-positive bacteria and fungi (Leclerc and Reichhart, 2004). Upon PRR recognition and serine 
protease activation, pro-Spätzle is processed to form Spätzle, which binds and activates the Toll 
receptors on cell membrane. The receptor then interacts with intracellular Myd88/Tube/Pelle and 
leads to the phosphorylation of Cactus. Phosphorylated Cactus dissociates from transcription 
factors Dif and Dorsal, allowing them to translocate to nucleus and induce AMP expression (Belvin 
and Anderson, 1996; Pinheiro and Ellar, 2006). The other is the IMD pathway in which most Gram-
negative bacteria are recognized by membrane-bound PGRP-LCs (Kurata, 2010). The intracellular 
domain of PGRP-LC forms complex with Imd/Dredd/Fadd and ultimately cleaves Relish, resulting 
in a DNA-binding N-terminal fragment (Hu and Yang, 2000; Naitza et al., 2002). This active Relish 
fragment translocates to nucleus and induce AMP expression (Hoffmann and Reichhart, 2002; 





Phenoloxidase (PO) is an important component of the insect immune system. It is synthesized 
as a zymogen prophenoloxidase (PPO), which is activated by proteolytic cleavage in vivo. PPO is 
primarily synthesized in insect hemocytes (Ashida and Brey, 1997), but other locations are also 
reported, like hindgut epidermal cells in the silkworm Bombyx mori (Shao et al., 2013) and hind 
wing of red flour beetle Tribolium castaneum (Dittmer et al., 2012). 
There are mainly three mechanisms for PPO activation (Lu et al., 2014). In B. mori, direct 
cleavage at Arg51-Phe52 by PPAE (PPO activating enzyme) is able to generate active PO 
(Yasuhara et al, 1995). In the tobacco hornworm Manduca sexta, PAP (PPO activating protease) 
cleavage at the same site (Arg51-Phe52 in MsPPO2) only generates a product with low PO activity. 
The cleavage has to occur in the presence of a high Mr complex of serine protease homolog-1 and 
-2 (SPH1 and SPH2) for the cleaved product to exhibit high PO activity (Jiang et al., 2003a, b; Yu 
et al., 2003; Gupta et al., 2005). In the beetle Holotrichia diomphalia and the fruit fly Drosophila 
melanogaster, PPO is first processed into a 76 kDa product with no activity, and then further 
cleaved to a 60 kDa high PO activity fragment (Lee et al., 1998; Kim et al., 2002; Lu et al., 2014a). 
In each model, the pathway is initiated via the binding of pathogen recognition receptors (PRRs, 
such as PGRPs, βGRPs) to pathogen associated molecular patterns (PAMPs, like peptidoglycans, 
β-1,3-glucan). Binding activates a downstream serine protease cascade, which finally leads to the 
activation of PPO. For example, the binding activates M. sexta hemolymph protease-14 (HP14), 
which cleaves proHP21 to form HP21. HP21 is responsible for the activation of proPAP2 and 
proPAP3 into PAP2 and PAP3 that cleave PPO. With the involvement of SPH1 and SPH2, PO is 
able to kill and melanize pathogens and parasites (Jiang, 2008). 
The biological substrate of PO is generally thought to be tyrosine (Clark and Strand, 2013). 
Under PO catalysis, tyrosine will be converted to L-dopa. After several subsequent steps of 
chemical transformation, melanin will be produced at last. An important intermediate in the process 
6 
 
is 5,6-dihydroxyindole (DHI) which has been demonstrated to be potent antibiotic (Zhao et al., 
2007; Charoensapsri et al., 2014). 
 
Serpins in Anopheles gambiae 
A total of 18 serpin genes have been identified in A. gambiae, which are SRPN1-14, 16-19 
(Suwanchaichinda and Kanost, 2009). Only two serpins have alternative splicing isoforms, SRPN4 
has three and SRPN10 has four. Most of the serpin genes form clusters: (SRPN1, 2, 3) and (SRPN7, 
14, 18) on chromosome arm 2L, (SRPN11, 12, 17) on 2R, and (SRPN5, 6, 16) on 3R. Sixteen 
serpins were predicted to contain secretory signal peptides, indicating they are probably 
extracellular proteins. The exceptions are SRPN10 and 12. SRPN10 was reported to be intracellular 
and was translocated from nucleus to cytoplasm upon Plasmodium infection (Danielli et al., 2003 
& 2005). Molecular mass of mature serpins in A. gambiae are generally 42−66 kDa. SRPN4A is 
unusually large (90.8 kDa). SRPN2 was demonstrated to inhibit CLIPB9 (An et al., 2011). SRPN1 
and 6 were shown to inhibit M. sexta PAPs (Michel et al., 2006; An et al., 2012), but the exact 
substrate in mosquito was not yet illustrated. SRPN13 was found to be expressed predominately in 
eggs and young larvae, pointing to a role in early development (Suwanchaichinda and Kanost, 
2009). 
 
Quantitative proteomic analysis 
Early proteomic studies employed two-dimensional gel electrophoresis to separate proteins 
from differently treated samples. Proteins of interest, such as differentially expressed gene 
products, were selected for mass spectrometry (MS) analysis. Although 2D gel is capable of 
distinguishing more than 1000 proteins, the number of proteins actually identified is far less. Also, 
it is impossible to resolve all proteins in one sample, and these reasons together prevent the method 
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from high-throughput applications (Schulze and Usadel, 2010). The next generation proteomic 
method takes advantage of stable isotopes to label proteins from different treatments or tissues. 
Isotopes can be chemically linked to proteins in vitro or metabolically incorporated into proteins in 
vivo. These proteins are then mixed and digested to produce differentially labeled peptides before 
LC-MS analysis. And peptides from different biological samples can be distinguished in MS due 
to the different masses of their isotopes (Schulze and Usadel, 2010). For example, in isotope coded 
affinity tag (ICAT), cysteine residues are covalently linked to the ICAT reagent, thus simplifying 
the system by focusing only on cysteines (Gygi et al., 1999). While stable isotope labeling 
approaches are the gold standard in protein detection, they have their limitations. First, they are 
time-consuming and relatively expensive in regarding to the labeling process and reagents needed. 
Also, comparisons can only be performed among 2−8 experiments due to technical constraints 
(Bantscheff et al., 2007). Recent years, label-free quantification (LFQ) methods are becoming more 
and more popular due to their ease of use (Asara et al., 2008). LFQ methods can be applied to all 
kinds of samples theoretically, and the number of experiments that can be compared is not limited. 
LFQ is based on spectral counting or the signal intensity of peptide precursor ions. The high-
resolution power uncouples the quantification and identification progress, and thus provide higher 
dynamic range for quantification. Also, LFQ intensities are normalized across the whole 
experiment, which corrects for technical and biological variations in peptide peak intensities (Cox 
et al., 2014). 
 
RNA interference 
RNA interference, historically known as post-transcriptional gene silencing (PTGS), was 
first reported in plants (Fire et al., 1998). The best application of this technology is that exogenously 
introduced double-stranded RNAs (dsRNAs) can result in down-regulation of target gene 
expression. Upon introducing into cytoplasm, long dsRNAs will be cleaved by Dicer (Bernstein et 
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al., 2001) to produce 20-25 nucleotide dsRNA duplexes with 2-nucleotide 3’ overhangs called 
small interfering RNAs (siRNAs) (Zamore et al., 2000; Vermeulen et al., 2005). siRNA is then 
unwound to passenger and guide strands, where only the guide strand is integrated into RNA 
inducing silencing complex (RISC) (Gregory et al., 2005). RISC is going to take advantage of the 
single-stranded guide RNA and mediate the cleavage of its complementary mRNA, which leads to 
PTGS (Ahlquist, 2002). The protein in RISC that mediates mRNA cleavage is called argonaute and 
it cleaves mRNA at the position corresponding to the middle of the guide RNA (Kupferschmidt, 
2013). The RNAi effect can be amplified when siRNAs are taken as templates by RNA-dependent 
RNA polymerase (RdRP) to produce more siRNAs (Pak et al., 2007; Sijen et al., 2007). Thus, a 
few dsRNA molecules are able to mediate gene knockdown of whole cell or organism. 
Endogenous RNAi can happen when microRNAs (miRNAs) encoded by RNA-coding genes 
are produced. miRNAs are transcribed firstly as pri-miRNAs with hairpin structures in the nucleus. 
Here, pri-miRNAs are processed by Drosha, a protein contains RNase III domain and dsRNA-
binding domain, to generate pre-miRNAs with stem-loop structures (Lee et al., 2002 & 2003). The 
pre-miRNA product is then transported via exportin-5 to the cytoplasm (Yi et al., 2003; Bohnsack 
et al., 2004), where it is further digested by Dicer to generate ~21 nucleotide RNA duplexes 
(miRNAs) to block translation (Elbashir et al., 2001). Thus, the two pathways (siRNA and miRNA) 
converges in downstream cascades (Gregory et al., 2006). 
 
Melanization and survival 
Results varied a lot in the survival tests upon melanization disruption in Drosophila 
melanogaster (see Table below). This may be due to differences in immune challenge and gene 
manipulation methods. In general, RNAi experiments didn’t elicit much change on survival, except 
that B. bassiana on Sp7 knockdown led to lower survival. Most challenges, including Gram-
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positive bacteria, yeast and fungi, on PPO1/2 mutants had lower survival rates comparing to the 
control. For Sp7/MP2 mutants, nearly half had lower survival and the other half remained the same. 
Only the S. pneumoniae challenge in Sp7/MP2 mutants showed higher survival across all 
experiments. Also, the same challenge under the same mutant and RNAi conditions had consistent 
or different survival rates (e.g. S. aureus in Sp7/MP2 mutants). In A. gambiae, the role of 
melanization in survival is less studied. Schnitger and colleagues reported that the survival of CTL4 
and CTLMA2 dsRNA-injected mosquitoes was reduced after Gram-negative bacterial infection, 
however the hemolymph PO activity of these mosquitoes was not altered (Schnitger et al., 2009). 
When PO activity and melanization were abolished by CLIPA8 knockdown, the survival of 











Mild Lower3   Same5 
Strong  Same4 Same4  
Gram-negative 
bacteria 
E. coli Same1,3    
E. carotovora  Same2 Same2 Lower5 
S. typhimurium Lower3   Same5 
E. cloacae    Same5 
B. cepacia Same3    
A. tumefaciens Same1    
Gram-positive 
(Lys) bacteria 
E. faecalis Same1,3 Same2 Same2 Lower5 
S. aureus Lower3+ 
Same1 
  Lower5 
S. saprophyticus    Lower5 
S. pneumoniae Higher3    
Gram-positive 
(DAP) bacteria 
L. monocytogenes Lower3   Lower5 
B. subtilis    Lower5 
Yeast C. ablicans  Same2 Same2 Lower5 
Fungi 
B. bassiana Same3 Same2 Lower2 Lower5 
M. anisopliae    Lower5 
A. fumigatus    Lower5 
*Survival results of melanization disruption in D. melanogaster (modified from reference 5). 1. 










A. gambiae G3 strain colony was maintained in an incubator where temperature, humidity 
and photoperiod were strictly controlled. Temperature was set to 27.5℃ and 80% relatively 
humidity was achieved by introducing a basin of water into the incubator. A 12h : 12h light-dark 
cycle with gradual sunset and sunrise transitions was programmed inside the incubator. To collect 
eggs, mosquito adults of 6 to 10-day-old were given a sheep blood meal (HemoStat Laboratories). 
Eggs were collected on wet filter papers and then transfer into distilled water to allow hatching. 
Larvae within first 2 days after hatching were feed on baker’s yeast, and the following instars were 
fed with larvae food (ground fish food plus baker's yeast at a ratio of 2:1 (w/w)). Pupae were picked 
and concatenated in cups with water for molting. Newly emerged adults were maintained by 10% 
sucrose solution until a blood meal was taken. 
 
Sample preparation for proteomic study 
Appropriate number of fourth instar larvae were transferred to new cups with clean water 
before infection. For infection, they were first dried on a filter paper, and then pricked in the thorax 
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with a pulled tiny glass needle that was previously dipped into E. coli pellets or distilled water 
(control). Then the larvae were transferred back to the same cup, and a little bit of larval food was 
provided. An incubation period of 24 h was allowed before hemolymph extraction, so that the 
infection would be given enough time to elicit responses. For hemolymph extraction, larvae were 
first dried and laid down on paraffin film. Then protease inhibitor solution prepared using cOmplete 
ULTRA Tablets, Mini (Roche) containing 0.1% 1-phenyl-2-thiourea (PTU, phenoloxidase 
inhibitor) were added onto them (5 μl for 5 larvae), and they were torn slightly with forceps in the 
thorax in solution. So, bleeding hemolymph would mix with protease inhibitors and PTU 
immediately, as the abdomen of mosquito larvae were pressed with pipette tips.  All samples 
(approximately 20 μl each tube) were centrifuged 5000 rpm (c.a. 2000×g) for 5 min to remove 
hemocytes and other contaminating tissues. Protein concentration of all samples were determined 
by a modified Bradford assay using BSA as a standard. A total of 40 μg total protein (volume 
adjusted to 20 μl by PBS) was taken from each of control and induced samples (4 biological 
replicates) and mixed with 4 μl 6×SDS sample buffer. After incubation at 95°C for 5 min, eight 
samples were loaded onto 4−15% gradient polyacrylamide gel (Mini-Protein TGX Precast Gels, 
Bio-Rad) and electrophoresed for 40 min at 25 mA. The gel was stained by Coomassie blue for 20 
min and destained for 1 h in 30% methanol and 10% acetic acid. Each lane was divided into 12 gel 
slices, resulting in 48 gel samples. Proteins in gel slices 1-5 (>80 kDa, 40 samples) were analyzed 
using a LTQ Orbitrap hybrid mass spectrometer (Thermo Fisher Scientific) without technical 
replicate. The remaining gel slices (56 samples) were analyzed on an Orbitrap Fusion tribrid mass 
spectrometer, and at least one technical replicate was performed for each sample. 
 
Proteomic data analysis 
Software MaxQuant was used to process raw data and perform database searching. Data from 
Orbitrap and Fusion mass spectrometers were analyzed together. For analysis between biological 
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replicates, gel slices from the same biological replicate were designated as one experiment (8 
experiments in total: CH1−4, IH1−4). For analysis across gel slices to look at protein distributions, 
gel slices were distinguished and designated as different experiments (96 experiments in total: 
CH(1−4)_(1−12), IH(1−4)_(1−12). Protein LFQ intensities in each gel slice (CH1−12, IH1−12) 
were represented by the average intensity in this slice across the biological replicates. Peptides were 
searched against A. gambiae protein database from VectorBase (Anopheles gambiae PEST 
PEPTIDES_AgamP4.2), with trypsin set as the digestion enzyme. Oxidation of methionine, 
acetylation of the protein N-terminus, iodoacetamide derivative of cysteine, pyro-Glu from 
glutamine and acrylamide adduct of cysteine were selected as variable modifications. No fixed 
modification was specified, and all peptides (with or without modifications) were used in searching. 
In protein search result, contaminants and proteins with one peptide count were not included in 
subsequent analysis. Here, we used the LFQ (label free quantification) intensity to calculate p value 
in Student’s t-test. Proteins with LFQ intensity of zero in all 8 biological replicates were excluded. 
For IH/CH ratio, it was calculated by dividing IH group mean over CH group mean. Signal peptides 
were predicted by SignalP 4.0 (Petersen et al., 2011), and those without SignalP output were 
predicted using Phobius (Käll et al., 2007) and Signal-3L (Shen and Chou, 2007) again. 
Hypothetical proteins were searched against NCBI non-redundant protein sequences using 
BLASTP 2.3.0+ (Camacho et al., 2009), and annotated either by BLAST description annotator in 
BLAST2GO or manually. Those not identified by BLAST were subjected to domain prediction by 
InterProScan 5, and representative domains were taken as protein names. Remaining unknown ones 
not identified by any method were represented with VectorBase IDs.  
 
PPO knockdown and mosquito survival 
Female mosquito adults within 1-2 days after emergence were anesthetized on ice, and 
injected with 69 nl (1 ng/nl) dsRNA to the thorax, either targeting A. gambiae PPO proteins 
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(AgPPOs) or GFP as a negative control. AgPPO dsRNA is designed to target a conserved region 
of A. gambiae PPOs, and it is able to knockdown all 9 PPO mRNAs to different extent. MEGAscript 
RNAi kit (Ambion) was used for dsRNA synthesis and purification, and Nanojet II (Drummond) 
was utilized for micro-injection. Mosquitoes were allowed to recover for 4 days before microbial 
infection was performed. For bacterial challenge, E. coli strain BL21 was cultured overnight, 
pelleted, re-suspended in sterilized PBS to a concentration of OD600 = 0.4. Each female mosquito 
received 69 nl bacteria suspension. Mosquito survival was recorded for a consecutive period of 
seven days, with dead individuals counted and removed daily. 
 
RNA analysis 
Total RNA of five mosquito adults was isolated using TRIzol Reagent (Ambion) 1 and 12 
days after dsRNA injection. Then first-strand cDNA was synthesized from total RNA using iScript 
Reverse transcription supermix for qRT-PCR (Bio-Rad) containing oligo-dT primers. The cDNA 
(400 ng) was used in a two-step qPCR protocol with iTaq Universal SYBR Green Supermix (Bio-
Rad) and CFX Connect Real-Time System (Bio-Rad). The melting curves of PCR products were 
examined with non-pure amplification excluded from subsequent analysis. qRT-PCR primers 
(Table 1, Appendices) were generated to specifically amplify AgPPO1−9 transcripts respectively, 
taking actin mRNA as an internal reference. 
 
Hemolymph PPO analysis 
15−20 female adults were decapitated 4 days post injection of dsRNA, and their hemolymph 
samples were extracted into 10 μl ddH2O containing 0.1% 1-phenyl-2-thiourea (PTU) and protease 
inhibitors (cOmplete ULTRA Tablets, Mini, Roche) using QIAshredder (QIAGEN). Hemolymph 
samples (3 μg total protein) were then subjected to western blot analysis. The hemolymph samples 
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were first separated by 6% SDS-PAGE and then transferred onto nitrocellulose membrane under 
15 V constant voltage for 80 min. Membrane was then blocked with 3% BSA in Tris-buffered 
saline (137 mM NaCl, 2.7 mM KCl, 25 mM Tris-HCl, pH 7.4) for 20 min and incubated with 1:500 
diluted polyclonal antiserum against Aedes aegypti PPO5 (AaPPO5) in TBS with 1% BSA 
overnight at room temperature. The recognition of AaPPO5 polyclonal antibody against AgPPOs 
was confirmed previously (Hu et al., unpublished data). After washing, the membrane was further 
incubated with alkaline phosphatase linked goat-anti-rabbit (GAR-AP) secondary antibody (1:1000 
diluted in TBS containing 1% BSA) for 4−6 h. Development was performed in 0.1M Tris-HCl, pH 
9.5 with 1% alkaline phosphatase (AP) color reagents A and B (Bio-Rad). 
 
PPO monoclonal antibody generation 
Antibodies are designed against peptide sequences (Table 2, Appendices) that are predicted 
to be on the surface of PPO proteins. The company (Ab-Mart, Shanghai, China) manually 
synthesized the peptides and conjugated them to BSA. Screening was performed using the 
conjugates across a well-established antibody library containing antibodies against all possible 
oligo-peptides. Positive hits were sent to us for verification and further examination on PPO 
proteins. 36 ng of each of the native PPO proteins (PPO1-9) were loaded onto nitrocellulose 
membranes. The membranes were blocked and cut into strips for probing with different primary 
antibodies (1:1000). Strips were further incubated in alkaline phosphatase linked goat-anti-mouse 
(GAM-AP) secondary antibody (1:1000) and developed in 0.1M Tris-HCl, pH 9.5 with 1% alkaline 








Overview of proteomic results 
There is no clear difference on band patterns between CH and IH lanes in polyacrylamide 
gel, suggestive of good repeatability and no major protein changes elicited by bacterial challenge 
(Fig. 1A). Each lane was cut into 12 gel slices in order to achieve comparable protein amounts and 
appropriate gel volume, as well as separating some intense bands from more diffused ones. By 
comparing with the protein marker, molecular mass ranges of the gel slices was estimated to be: 
500−350, 350−250, 250−230, 230−140, 140−80, 80−70, 70−45, 45−30, 30−22, 22−20, 20−15, <15 
kDa from top to bottom, corresponding to slices 1−12, respectively (Fig. 1A). Indeed, the number 
of proteins identified (LFQ intensity not zero) in each gel slice was consistent across the two 
groups. For CH, there are 583, 674, 544, 806, 765, 817, 1023, 1197, 1189, 781, 981, 958 proteins 
in slice 1−12; For IH, there are 687, 744, 698, 859, 742, 864, 1061, 1206, 1178, 890, 949, 907 
proteins, confirming a good parallellism between experiments (Fig. 1B). Although slice 7−9 
contain more proteins, identified protein numbers are comparable between gel slices, suggesting 
the gel cutting procedure was properly-designed. In order to further investigate the correlation 
between biological samples, we did a pairwise Pearson correlation analysis (Table 1). Correlation 
within groups are high: 0.897−0.978 (mean ± SD, 0.937 ± 0.029) for CH-CH, and 0.959-0.991
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 (0.976 ± 0.011) for IH-IH, suggesting good consistency among biological replicates. For 
comparison between CH and IH, the correlation is lower (0.908−0.954; mean ± SD: 0.941 ± 0.020), 
but not well separated from the intragroup correlations, demonstrating that no major protein change 
was induced by microbial challenge again. 
Overall, we have identified 1,756 proteins after excluding those with only one peptide count. 
After determining their names by BLAST and InterProScan, we divided them into nine categories: 
immunity-related, metabolism, DNA/RNA & nucleus, ion binding, cytoskeleton/motor, ATP/NAD 
binding, sensory/cuticle, ribosomal protein and other, and each of them contains 235, 524, 105, 
147, 73, 181, 52, 78, and 361 proteins (Fig. 2A), respectively. This includes a wide range of 
molecules, some of which were not expected to be presented in larval plasma. Among them, 602 
proteins were predicted to contain signal peptides, and others were supposed to be intracellular. 
This may be due to the hemolymph collection procedure. In the procedure, we pressed the larval 
abdomen in order to extract more hemolymph, which may have led to contamination by gut content. 
Hemocyte rupture and incomplete removal of hemocytes by centrifugation can also result in the 
presence of intracellular proteins in MS results. However, the abundance of extracellular proteins 
are almost two thirds of the total protein abundance (69.7% in CH, 64.6% in IH), which is twice 
higher than the intracellular ones. That means the contamination is not severe, although there are 
quite a few number of intracellular proteins. 
 
Most abundant proteins 
We examined the distribution of proteins based on their abundance (Fig. 3A). There are 61 
proteins identified in CH but not in IH (LFQ of IH is zero), and 68 proteins vice versa. Within total 
LFQ intensity ranges of <1×106, 1×106 to 1×107, 1×107 to 1×108, 1×108 to 1×109, 1×109 to 1×1010, 
and >1×1010, we identified 35, 339, 698, 453, 140, 23 proteins in CH, and 48, 340, 702, 444, 140, 
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21 proteins in IH. They are almost normally distributed. Then we calculated the total abundance of 
proteins within each LFQ range and represented them as percentage of the total protein abundance 
of CH or IH (Fig. 3B). Surprisingly, a few molecules represents more than half of the protein 
abundance in both groups. The 23 and 21 most abundant proteins in CH and IH account for 62.2% 
and 54.3% of the total protein amounts, respectively. Also, the 140 less abundant proteins in both 
groups account for 25.5% and 31.1% accordingly. 
We closely examined the 23 and 21 (total 25) most abundant proteins (Table 2). Different 
isoforms of hexamerin compose a large proportion (27.8% for CH and 24.5% for IH in abundance) 
of the hemolymph proteins. They are also known as storage proteins in insects. Apolipophorin-III 
alone accounts for 7% of the total protein abundance. It associates with low density lipophorin 
(LDLp) and facilitates the transport of diacylglycerols in plasma. Also, vitellogenin, an egg yolk 
precursor, comprises 4−5% of the total protein amount. Actin is an intracellular protein and 
important component of cytoskeleton. It is a house-keeping gene and usually adopted as internal 
references. Its presence in the hemolymph probably results from incomplete removal of hemocytes 
or gut contamination. It is also the case with other intracellular metabolic enzymes, like creatine 
kinase, fructose-bisphosphate aldolase and glyceraldehyde 3-phosphate dehydrogenase. Gelsolin is 
a regulatory protein of the actin filament, and here we identified the extracellular form of this 
protein. Ferritin is a protein that stores and transports iron in the serum. Studies have also shown 
its role in immune and stress response (Larade and Storey, 2004; Ong et al., 2005). It is quite 
surprising to find PPO2 and PPO3 are among the most abundant proteins. They probably remain 
in inactive state in plasma prior to acute activation. TEP15 is a member of the TEP family, which 
belongs to the complement C3/α2 macroglobulin superfamily. One family member TEP1 was 
demonstrated to promote parasite melanization (Blandin et al., 2004) and bacteria phagocytosis 
(Levashina et al., 2001). 
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Moreover, we examined the presence of proteins in each gel slice. In the beginning, we 
divided the gel in a way that the intense bands could be separated (Fig. 1A). Here, we examined 
the contents of these three bands: slice 3 (250-230 kDa), slice 6 (80-70 kDa) and slice 10 (22-20 
kDa). Different isoforms of hexamerin together account for 57% of CH and 47%  of IH total protein 
amounts in slice 3. Similarly, hexamerin isoforms account for 53% of CH and 34% of IH in slice 
6. It is much simpler in slice 10 – apolipophorin III alone represents most of the protein abundance 
(74% of CH and 67% of IH). Therefore, we conclude that the intense bands in slices 3, 6 and 10 
are mainly hexamerins, hexamerins and apolipophorin III. 
 
Up- and down-regulated proteins 
A total of 158 proteins are significantly different (p <0.05) in abundance between CH and 
IH. 109 were up-regulated (IH/CH >1, minimum: 1.14) (Table 3) and 49 were down-regulated 
(IH/CH<1, maximum: 0.85) (Table 4) after E. coli challenge. They account for 9% of the total 
proteins identified. Surprisingly, only twenty are related to immunity. Their IH/CH ratios are close 
to 1.0 in most cases. 119 out of the 158 proteins (p < 0.05) have IH/CH ratio of 0.5−2, and 144 
have IH/CH ratio of 0.3−3. One reason for this unusual phenomenon may be that, after pricking 
and placing the larvae back into aqueous environment, bacteria can diffuse into water through the 
wound site. On the other hand, due to wounding and exposure to food-containing water, the control 
larvae may be infected. 
The 109 up-regulated proteins are devided into six groups: immunity-related, cytoskeleton/ 
motor, DNA/RNA & nucleus, metabolism, ATP/NAD binding, and other functions, with each 
comprised of 5, 10, 16, 37, 12 and 29 proteins (Table 3), respectively. Only 14 of them were 
predicted to be extracellular. The five immunity-related proteins are E3 SUMO-protein ligase 
RanBP2, LRR15, PGRP-LB, SRPN10B and TEP2, and their IH/CH ratios are 2, 1.34, 2.24, 1.93 
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and 1.51, respectively. Involvement of nucleus and DNA/RNA binding proteins may reflect 
regulations in transcription and translation in response to bacterial challenge. And indeed, quite a 
few of them are translation initiation factors. Also, microbial challenge can disturb the metabolism 
of the host, resulting in metabolic changes partly reflected by enzymes or other related proteins 
(e.g. ATP/NAD binding proteins) to resist invading pathogens. In the “other” group, some heat 
shock proteins and stress-induced proteins may be induced by injury or infection. 
The 49 down-regulated proteins belong to three categories: immunity-related, metabolism 
and other, with 15, 19 and 15 proteins in each group, and signal peptides were predicted to be 
present in half (26) of them (Table 4). Interestingly, immunity-related proteins account for 31% of 
the down-regulated proteins. Indeed, 70% (158) of the 235 immunity-related proteins were found 
to have IH/CH ratio less than 1. In other words, there is a tendency for immunity-related proteins 
to be down-regulated in A. gambiae larvae after E. coli challenge. The 15 significantly down-
regulated immune proteins were CLIPA7 homolog, CLIPB1, B8, B13, PPO1, PPO2, PPO3, βGBP, 
LRR1, TEP15, MDL2, lysozyme-4 (c-type), fibrinogen, coagulation factor X, and a chymotrypsin-
like protease. Their IH/CH ratios are within 0.34−0.85. 
 
Immunity-related proteins 
A total of 235 immunity-related proteins were identified in our experiment, and 166 (71%) 
of them were predicted to be secretory (Table 5). Some proteins do not contain signal peptides but 
actually present in plasma, like PPOs, may result from cell rupture. These immunity-related 
proteins were further divided into 8 groups: AMP, PPO, TEP, PRR, SP, SPH, Serpin and other, 
with 9, 7, 8, 40, 63, 37, 15 and 56 proteins in each group (Fig. 2B), respectively. Unlike in Manduca 
sexta (Zhang et al., 2014), we identified only a small number of antimicrobial peptides (AMPs), 
including defensin, gambicin, transferrin and lysozyme. However, we detected seven 
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prophenoloxidaes (PPO1−4, 6−8) in the larval hemolymph. PPO2 and PPO3 are most abundant; 
PPO6 and PPO8 are moderate; PPO1, PPO4 and PPO7 are low. A few members of the thioester-
containing proteins (TEPs), complement-like proteins in insects, were also identified, including 
TEP1, 2, 4, 6, 9, 12, 14, and 15. The function of TEP1 is well characterized while others remain 
unclear (Levashina et al., 2001; Blandin et al., 2004). Pathogen recognition receptors (PRRs) are 
important molecules which distinguish nonself from self in the host. Typical PRRs include βGBPs, 
CTLs, GNBPs, LRIMs, LRRs, and PGRPs, some of which were identified in this study. Serine 
proteases (SPs) and serine protease homologs (SPHs) comprise the largest groups, accounting for 
43% of the immunity-related proteins. They are (chymo)trypsin-like proteins without or with clip-
domains (CLIPs). CLIPs are major components of the hemolymph serine protease cascade which 
leads to the activation of PPOs or cytokines for signal transduction receptors on cell membrane 
(Cao et al., 2015), and 31 (including serine protease homologs) of them are found here. Many 
serpins are serine protease inhibitors that inhibit the activity of hemolymph proteases. There are 19 
SRPNs in A. gambiae, and we identified 12: SRPN1−4, 7−12, 16, and 17. Other identified immune 
proteins include FBNs, fibrinogens, thioredoxins, thioredoxin peroxidases and so on. 
 
Gel distribution of immune proteins 
Theoretically, proteins should migrate to the position corresponding to their calculated 
molecular masses (Mr’s) in polyacrylamide gel. However, multiple reasons can lead to irregular 
distribution patterns from calculated, such as post-translational modifications (e.g. glycosylation) 
(Table 6). We examined the gel distribution patterns of immunity-related proteins (Table 3, 
Appendices) and identified major discrepancies from theoretical Mr values. For some proteins, their 
abundances are very high and they are presented in nearly all 12 gel slices both in CH and IH (data 
not shown). To explain this, we examined the correlation between protein abundance and number 
of slices the protein presented. There is a trend for more abundant proteins to be found in more gel 
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slices (Fig. 4). Other than that, proteins over 160 kDa tend to migrate to lower positions with Mr 
less than 80 kDa, which may be due to proteolytic cleavage. Proteolytic cleavage can also account 
for the discrepancies of many serine proteases, since they exist as zymogens and need cleavage to 
become active (Table 6). Another possibility for the discrepancies of serine proteases is their 
complex formation with serpins, which results in SDS-stable 70-80 kDa molecules. In M. sexta, 
serpin-1E was known to form complex with HP1 and HP8 (Ragan et al., 2010). Serpin-3 through 
6 were known to associate with PAPs and HP1, 6, 8, 21. In A. gambiae, however, it is not well-
understood. Only SRPN2 was reported to form complex with CLIPB9 (An et al., 2011). SPRN1 
and 6 were shown to inhibit M. sexta PAPs (Michel et al., 2006; An et al., 2012), but the substrate 
in mosquito was not illustrated. Nonetheless, it is likely that many serpins are able to form SDS-
stable complexes with serine proteases in mosquito. In our results, quite a few CLIPs and serpins 
were found to form possible serpin-protease complexes in 70-80 kDa (slice 6), especially 
SRPN10D which exists 100% in slice 6 (Table 7). There is another type of discrepancy that cannot 
be explained with protein abundance, proteolysis or complex formation. Many proteins migrate to 
the first few gel slices (>140 kDa) which is far beyond their theoretical molecular mass. These 
include 4 trypsin-like proteins, 4 LRRs, 4 coagulation factor XI, 5 TEPs and 6 PPOs, and can be 
interpreted as components of high mass immune complexes (Table 8). 
 
Examination of PPO monoclonal antibodies 
To facilitate the detection of specific PPOs in tissues, we asked a company to develop and 
screen monoclonal antibodies against 29 unique and 3 common surface peptides of A. gambiae 
PPO2, 6, 7 and 8 (Table 2, Appendices). According to the company, 54 antibodies were generated 
against 27 peptides, 49 of which have detection limits below 25 ng against BSA-peptide conjugates. 
However, when all the antibodies were tested against native recombinant A. gambiae PPOs, only 
two (1P5 and 3P35) showed successful recognition at a sensitivity of 36 ng PPO2 and PPO7, 
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respectively (data not shown). Antibody 3P35 showed some cross-reactivity with BSA. After 
changing the blocking solution to 3% BSA in TBS and pre-incubating 3P35 with 1% BSA in TBS 
for 1h, the cross-reactivity was eliminated while the recognition on PPO7 remained unchanged. 
Antibody 1P5 reacted weakly with PPO7, and both antibodies were able to recognize denatured 
PPOs at a sensitivity of ~400 ng. 
 
Mosquito hemolymph PPOs 
According the proteomic results, the abundance of PPO2 and 3 are most abundant, PPO6 and 
8 are moderate, PPO1, 4 and 7 are low. To confirm this using the monoclonal antibodies, we 
examined the expression profile of PPOs in hemolymph samples from mosquito larvae, pupae and 
adults (Fig. 5). In larva and pupa, not much signal was detected by 1P5 (against AgPPO2) and 3P35 
(against AgPPO7) at the position of recombinant PPO, while there were proteins identified by the 
polyclonal antibody that recognizes all AgPPOs. In adult, however, one strong band was detected 
by 1P5, while no PPO7 was identified by 3P35. Although 1P5 cross-reacts with PPO7, since no 
PPO7 was detected, the band must be PPO2. There is also one band lower than PPO2/7 under 
AaPPO5 in adult, which may be other PPO isoforms (Fig. 5). The lack of PPO2 signal in larval 
hemolymph may be due to the low sensitivity of monoclonal antibodies comparing to mass 
spectrometry. 
 
PPO knockdown and mosquito survival 
There has being a long-existing debate about whether PPO is needed or not for mosquito 
immune response. But till present, direct evidence from PPO knockdown is not reported. In our 
proteomic result, PPO1−3 was shown to be down-regulated after E. coli challenge, indicating a role 
of PPOs in anti-bacterial response. Here, we tried to knockdown them by dsRNA injection and 
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examine the survival of mosquitoes upon bacterial challenging. Female mosquitoes (~40 per group) 
within 1-2 days of emergence were injected with either dsPPO or dsGFP (as negative control). The 
knockdown efficacy was confirmed by qRT-PCR and immunoblotting (Fig. 6), which 
demonstrated successful silencing at both mRNA and protein level. After four days of recovery, 
both groups were injected with E. coli of OD600 = 0.4 for the survival test. Survival was documented 
for the following seven days. The result didn’t show significant difference between dsPPO and 
dsGFP groups (Fig. 7). One possible explanation is that the knockdown is not significant enough 
to elicit observable responses or not long-lasting enough to cover the documenting period. We have 
examined the PPO mRNA levels 12 day post dsRNA injection, which would be seven days post E. 
coli infection. The qRT-PCR data showed only 2 PPO genes still had significant knockdown (data 
not shown). Another possibility is that PPOs are not indispensable for mosquito immunity, which 








In the present study, we identified a total of 1,756 proteins in the hemolymph of A. gambiae 
larvae. Although 69% of them are predicted to be intracellular, they only constitute a small portion 
(c.a. 33%) of the total protein amount. Among all these proteins, 109 (14 extracellular) were up-
regulated and 49 (27 extracellular) down-regulated. IH/CH ratios for 1,577 proteins were not 
substantially changed (0.33−3) after the immune challenge. This may be related to the aquatic 
habitat of mosquito larvae, which may have affected the test. PPO1−3 and TEP15 were down-
regulated. PPO2, PPO3 and TEP15 are among the most abundant proteins, including hexamerins, 
apolipophorin III, OBP9, ferritin and vitellogenin. We consider 235 proteins (70% extracellular) as 
defense-related. 100 (42%) of them are serine protease-related, suggesting these proteins play an 
important role in mediating immune responses in hemolymph. We examined the gel distribution 
patterns of all the proteins and found that abundant proteins tend to spread to more gel slices. 
Besides, while distributions of some proteins can be explained by post-translational modifications 
such as proteolysis, others suggest the existence of serpin-protease complexes and high Mr immune 
complexes. In addition to the proteomic study, we generated monoclonal antibodies against PPO2 
and PPO7, and used them to examine their presence in mosquito hemolymph. Immunoblot analysis 
showed PPO2 (and not PPO7) is present in hemolymph of the adult mosquitos. We examined the 
role of PPOs in antibacterial defense in mosquito by knocking down PPO expression in adult 
females. E .coli infection of the adults did not cause any significant difference in survival between 
GFP and PPO dsRNA-treated groups.
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Table 1. Pearson correlation between biological replicates 
 CH1 CH2 CH3 CH4 IH1 IH2 IH3 IH4 
CH1 1 0.915 0.948 0.897 0.965 0.98 0.965 0.918 
CH2  1 0.978 0.956 0.943 0.924 0.921 0.908 
CH3   1 0.929 0.938 0.954 0.935 0.918 
CH4    1 0.949 0.936 0.942 0.954 
IH1     1 0.977 0.984 0.959 
IH2      1 0.991 0.967 
IH3       1 0.978 
IH4        1 
 
 
Table 2. A list of 25 most abundant proteins 
Protein IDs Protein names MW (kDa) SP* CH% IH% IH/CH p-value 
AGAP000651-PC Actin 41.8  0.64 0.84 1.12 0.458 
AGAP013365-PA Apolipophorin-III 21.7 19 7.07 7.16 0.86 0.642 
AGAP008054-PD Chemosensory protein 14.6 17 1.68 1.23 0.63 0.126 
AGAP005627-PD Creatine kinase 39.8  1.09 1.37 1.07 0.643 
AGAP002564-PE Fructose-bisphosphate aldolase, class I 39.2  0.97 1.43 1.26 0.168 
AGAP011369-PA Gelsolin 42.7 20 0.78 0.49 0.54 0.053 
AGAP009623-PA Glyceraldehyde 3-phosphate dehydrogenase 35.5  0.77 0.72 0.8 0.49 
AGAP001659-PA Hexamerin 83.9 19 7.99 6.41 0.69 0.019 
AGAP001657-PA Hexamerin 84.2 18 9.1 6.36 0.6 0.039 
AGAP005768-PA Hexamerin 82.3 18 1.15 2.75 2.04 0.138 
AGAP005766-PA Hexamerin A 38.9 18 2.71 3.7 1.17 0.441 
AGAP001345-PA Hexamerin A 82.8 18 6.8 5.28 0.66 0.05 
AGAP008060-PA Imaginal disc growth factor 48.1 22 0.88 0.94 0.91 0.706 
AGAP010657-PA Larval serum protein 1 beta chain 23.5 18 1.26 1.68 1.14 0.351 
AGAP008369-PA Lipid transport protein vitellogenin 170.4 19 4.71 4.06 0.74 0.294 
AGAP001826-PA Lipophorin 371.3  2.5 1.1 0.38 0.036 
AGAP007059-PA LRR-7059 124  0.72 0.67 0.79 0.106 
AGAP000278-PA OBP9 15.7 17 2.98 1.83 0.52 0.051 
AGAP006258-PA PPO2 78.1  1.19 1.18 0.85 0.045 
AGAP004975-PA PPO3 78.6  2.1 1.96 0.8 0.024 
AGAP013400-PA Probable fatty acid-binding protein 14.7  0.67 1.34 1.72 0.021 
AGAP012057-PA RNA polymerase-associated protein RTF1 88.4  0.93 0.49 0.45 0.008 
AGAP002464-PA Ferritin G subunit 26.2 21 2.05 1.45 0.6 0.082 
AGAP002465-PA Ferritin heavy chain 24.6 26 1.13 0.8 0.61 0.032 
AGAP008364-PA TEP15 163.6 42 1.66 1.41 0.73 0.045 
*SP indicates the predicted signal peptide cleavage site, and TMs indicates the predicted number of transmembrane domains. CH% 




Table 3. A list of 109 up-regulated proteins 
Group Protein IDs Protein names SP* TMs IH/CH p-value 
Immunity-related 
AGAP002982-PA E3 SUMO-protein ligase RanBP2   2 0.021 
AGAP003878-PA LRR-15 19 1 1.34 0.013 
AGAP001212-PB PGRPLB  1 2.24 0.04 
AGAP005246-PD SRPN10B   1.93 0.044 
AGAP008366-PA TEP2   1.51 0.021 
Cytoskeleton/ motor 
AGAP001306-PA Actin related protein 2/3 complex, subunit 4   1.48 0.042 
AGAP002509-PA Actin-interacting protein 1   1.4 0.018 
AGAP010175-PC Adenylyl cyclase-associated protein 1   1.49 0.034 
AGAP012185-PA Erythrocyte membrane protein band 4.1   1.8 0.008 
AGAP004335-PA Filamin   1.37 0.017 
AGAP001315-PE Microtubule-associated protein 7 family   2.1 0.022 
AGAP000749-PA Muscular protein 20   1.34 0.043 
AGAP010895-PA Spectrin beta   1.46 0.016 
AGAP001799-PA Tropomyosin 1   1.52 0.008 
AGAP002130-PA Tubulin-specific chaperone A   1.43 0.003 
DNA/RNA 
& nucleus 
AGAP002945-PA Bifunctional glutamyl/prolyl-tRNA synthetase   2.61 <0.001 
AGAP006125-PA Density-regulated protein   1.78 0.048 
AGAP001883-PA ELAV-like 1   2.3 0.002 
AGAP002340-PA Eukaryotic translation initiation factor 3A   1.45 0.039 
AGAP004725-PA Eukaryotic translation initiation factor 3C   2.16 0.002 
AGAP002337-PA Eukaryotic translation initiation factor 3D   1.33 0.033 
AGAP003486-PA General transcriptional corepressor trfa   1.9 0.044 
AGAP005015-PA Heterogeneous nuclear ribonucleoprotein K   1.75 0.029 
AGAP007299-PA Importin-7   1.64 0.014 
AGAP012013-PA Nuclear factor of activated T-cells 5   1.69 0.009 
AGAP002351-PA Nuclear pore complex protein Nup98-Nup96   4.67 0.005 
AGAP002654-PB Poly(A)-binding protein 1   1.87 0.04 
AGAP010553-PA Poly(U)-binding-splicing factor PUF60   1.63 0.035 
AGAP002655-PA RNA binding protein   2.88 0.045 
AGAP010640-PA Translation initiation factor   1.68 0.003 
AGAP002502-PA Translation initiation factor 4G   1.48 0.02 
Metabolism 
AGAP011350-PA 4-nitrophenyl phosphatase   1.41 0.029 
AGAP006227-PA Alpha esterase   ∞ 0.026 
AGAP007809-PA Aminopeptidase NPEPL1   1.26 0.036 
AGAP004236-PA Beta-lactamase-like protein 2 homolog   ∞ 0.024 
AGAP001341-PA Bleomycin hydrolase   1.43 0.045 
AGAP004940-PA cAMP-dependent protein kinase regulator   1.41 0.028 
AGAP009405-PA CPAP3-E 24  1.59 0.037 
AGAP005627-PE Creatine kinase   10.27 0.027 
AGAP003124-PA Dihydropyrimidinase   2.47 0.047 
AGAP001021-PB Dihydropyrimidine dehydrogenase   1.32 0.025 
AGAP000513-PB Dipeptidase E 23  1.81 0.032 
AGAP004394-PA Dipeptidyl-peptidase III   1.38 0.029 
AGAP013400-PA Fatty acid-binding protein   1.72 0.021 
AGAP004071-PB Fimbrin   1.63 0.009 
AGAP006670-PA Gamma-glutamyl hydrolase 33  1.91 0.049 
AGAP001512-PA Glutamate-cysteine ligase catalytic subunit   1.4 0.027 
AGAP003077-PB Glutamyl aminopeptidase  1 1.72 0.05 
AGAP004383-PA GSTD10   3.07 0.01 
AGAP009191-PA GSTE6   1.35 0.041 
AGAP003257-PA GSTU2   2.03 0.035 
AGAP006353-PA Histidine triad nucleotide binding protein 1   1.58 0.049 
AGAP004747-PA Ion binding and proteolysis   1.58 0.049 
AGAP012008-PA Na+/H+ exchange regulatory cofactor NHE-RF1   2.05 0.003 
AGAP007700-PA N-acetylneuraminate lyase   1.33 0.04 
AGAP000500-PD NADPH-ferrihemoprotein reductase   ∞ 0.001 
AGAP008305-PC Phosphoglucomutase   1.14 0.03 
AGAP009172-PA Prolyl oligopeptidase 15  1.56 0.006 
AGAP004758-PB Proteasomal ubiquitin receptor adrm1 homolog   1.8 0.047 
AGAP006171-PA Protein phosphatase   ∞ <0.001 
AGAP005929-PA Pyridoxine kinase   1.46 0.012 
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AGAP004093-PA Sterol carrier protein-2   2.25 0.036 
AGAP003052-PA Tetratricopeptide repeat-containing protein alpha   1.62 0.029 
AGAP004870-PA Tripeptidyl-peptidase II   1.46 0.025 
AGAP011872-PA Ubiquitin-activating enzyme E1   1.61 0.023 
AGAP001056-PA Ubiquitin-conjugating enzyme E2 L3   1.32 0.029 
AGAP009841-PA UBX domain-containing protein 1   1.67 0.039 
AGAP009648-PA Ureidoimidazoline decarboxylase   1.59 0.013 
ATP/NAD binding 
AGAP003405-PA Adenylosuccinate synthase   1.28 0.038 
AGAP005981-PA DnaJ homolog subfamily A   1.87 0.001 
AGAP000970-PA DnaJ homolog subfamily C   1.26 0.036 
AGAP012010-PA Fructose-2,6-bisphosphatase   1.23 0.038 
AGAP007699-PC GTP-binding nuclear protein Ran   1.43 0.002 
AGAP011208-PA Hexokinase   1.47 0.012 
AGAP001690-PA Regulating synaptic exocytosis protein 2   ∞ 0.028 
AGAP003153-PD V-type proton ATPase catalytic subunit A   1.9 0.006 
AGAP009486-PA V-type proton transporting ATPase 54 kDa  2 1.97 0.026 
AGAP002884-PA V-type proton transporting ATPase subunit B   1.76 0.018 
AGAP005845-PA V-type proton transporting ATPase subunit C   1.41 0.013 
AGAP002401-PA V-type proton transporting ATPase subunit E   1.41 0.019 
Other 
AGAP001467-PA AGAP001467-PA   1.87 0.032 
AGAP013060-PA AGAP013060-PA 20 1 2.71 0.048 
AGAP011762-PA BAG domain-containing protein Samui   1.59 0.015 
AGAP010557-PA B-cell receptor-associated protein 31  3 1.66 0.003 
AGAP005316-PA Charged multivesicular body protein 4   1.71 0.008 
AGAP010251-PA Coatomer protein complex alpha subunit   2.37 0.038 
AGAP004625-PB Cortactin   1.32 0.027 
AGAP010900-PA Cuticular protein 1 from fifty-one aa family 17  1.72 0.015 
AGAP005997-PA Cuticular protein RR-1 family 17  1.46 0.021 
AGAP006103-PA Farnesoic acid o-methyl transferase-like   1.81 0.009 
AGAP009738-PA Glutaredoxin   1.66 0.015 
AGAP010331-PA heat shock protein 110kDa   1.39 0.012 
AGAP013228-PA Heat shock protein 67B2   1.43 0.001 
AGAP000941-PB Heat shock protein beta-1 isoform x2   1.77 0.012 
AGAP000941-PA Heat shock protein beta-1 isoform x2   1.76 0.007 
AGAP007310-PA Klaroid  2 1.59 0.005 
AGAP005291-PA Lupus la ribonucleoprotein   1.63 0.008 
AGAP003238-PC N-myc downstream regulated protein   1.62 0.022 
AGAP005369-PA NOLC1-like isoform x2   3.27 0.015 
AGAP008747-PA Nsp1p   2.02 0.03 
AGAP008046-PA PACSIN2   3.91 0.004 
AGAP004310-PA Perq amino acid-rich  protein 2   1.59 0.036 
AGAP012746-PA Phyhd1 protein   1.58 0.029 
AGAP006946-PA Prefoldin subunit 4   1.41 0.034 
AGAP003612-PA Protein CDV3 homolog   1.35 0.013 
AGAP004520-PA Ran-binding protein 3   1.83 0.007 
AGAP010188-PA Stress-induced-phosphoprotein 1   1.3 0.037 
AGAP004273-PB Synapse-associated protein   2.96 0.025 
AGAP000626-PA Vesicle-associated membrane protein B  1 1.67 0.03 
*SP indicates the predicted signal peptide cleavage site, and TMs indicates the predicted number of transmembrane domains.  
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Table 4. A list of 49 down-regulated proteins 
Group Protein IDs Protein names SP* TMs IH/CH p-value 
Immunity-related 
AGAP009110-PA GNBP 24  0.52 0.004 
AGAP005663-PA Chymotrypsin-like protease 34 1 0.61 0.026 
AGAP011792-PA CLIPA7 homolog 21  0.52 0.011 
AGAP003251-PA CLIPB1 25  0.5 0.004 
AGAP004855-PA CLIPB13 22  0.74 0.036 
AGAP003057-PA CLIPB8 24 1 0.52 0.048 
AGAP005072-PA Coagulation factor X 14  0.53 0.002 
AGAP006743-PA Fibrinogen   0.79 0.042 
AGAP004832-PA LRR-1  1 0.7 0.03 
AGAP007385-PA Lysozyme 4 (c-type) 31 1 0.37 0.046 
AGAP002857-PB MDL2 25 1 0.5 0.02 
AGAP002825-PA PPO1   0.34 0.031 
AGAP006258-PA PPO2   0.85 0.045 
AGAP004975-PA PPO3   0.8 0.024 
AGAP008364-PA TEP15 42  0.73 0.045 
Metabolism 
AGAP000558-PA 1,2-alpha-mannosidase   0.7 0.047 
AGAP003490-PA Alanine-glyoxylate aminotransferase   0.64 0.032 
AGAP000862-PA Alpha 1,3-glucosidase 22  0.78 0.03 
AGAP000679-PA Aminoacylase   0.76 0.033 
AGAP008783-PA Arginase   0.57 0.004 
AGAP000985-PA ARP2 actin-related protein 2 homolog   0.81 0.017 
AGAP000756-PB Carboxypeptidase M 22  0.75 0.026 
AGAP006726-PA COEAE5G   0.67 0.02 
AGAP000162-PA Cystathionine beta-synthase   0.71 0.001 
AGAP002465-PA Ferritin heavy chain 26  0.61 0.032 
AGAP011107-PA Glutaredoxin   0.74 0.021 
AGAP008798-PA Guanine nucleotide exchange factor MSS4   0.16 0.011 
AGAP007237-PA Heme peroxidase 37  0 0.024 
AGAP009033-PA Heme peroxidase 18  0.56 0.015 
AGAP001826-PA Lipophorin   0.38 0.036 
AGAP004654-PA Phosphoadenylate 3'-nucleotidase   0.39 0.047 
AGAP008096-PA Sphingomyelin phosphodiesterase 22 1 0.73 0.02 
AGAP000439-PA Tetrahydrobiopterin dehydratase   0.63 0.02 
AGAP008064-PA Uroporphyrinogen-III synthase   0.64 0.032 
Other 
AGAP010846-PA AGAP010846-PA   0.29 0.036 
AGAP028095-PC AGAP028095-PC 21  0.47 0.005 
AGAP004108-PB Amalgam 13  0.59 0.02 
AGAP008052-PA Chemosensory protein 17  0.61 0.039 
AGAP002822-PA Condensin-2 complex subunit H2   0.16 0.003 
AGAP008013-PA Filaggrin-2 isoform x1 18  0.63 0.013 
AGAP001768-PB Gamma-interferon-inducible protein IP-30 32 1 0.49 0.038 
AGAP001657-PA Hexamerin 18  0.6 0.039 
AGAP001659-PA Hexamerin 19  0.69 0.019 
AGAP005471-PA Muscle M-line assembly protein unc-89   0.7 0.009 
AGAP001127-PA P37NB protein 24 1 0.42 0.033 
AGAP012057-PA RNA polymerase-associated protein RTF1   0.45 0.008 
AGAP001989-PA Secreted salivary gland protein 24 1 0.41 0.013 
AGAP007532-PA Vinculin   0.7 0.033 
AGAP003095-PA Yellow protein 21  0.71 0.003 
*SP indicates the predicted signal peptide cleavage site, and TMs indicates the predicted number of transmembrane domains.  
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Table 5. A list of 235 immunity-related proteins 
Group Protein IDs Protein names MW (kDa) SP* TMs IH/CH p-value 
AMP 
AGAP004632-PA Defensin 10  1 27.53 0.356 
AGAP007199-PA Defensin 7 22  2.08 0.341 
AGAP008645-PA Gambicin 8.8 20 1 2.67 0.089 
AGAP007347-PA Lysozyme 1 (c-type) 15.3 20  0.76 0.64 
AGAP007345-PA Lysozyme 3 (c-type) 16.6 18  1.12 0.817 
AGAP007385-PA Lysozyme 4 (c-type) 17.4 31 1 0.37 0.046 
AGAP007344-PA Lysozyme 8 (c-type) 16.5 18  13.93 0.356 
AGAP011119-PA Lysozyme 3 18 21  0.98 0.916 
AGAP000376-PA Transferrin precursor 69.2 18  1.61 0.055 
PPO 
AGAP002825-PA PPO1 79.3   0.34 0.031 
AGAP006258-PA PPO2 78.1   0.85 0.045 
AGAP004975-PA PPO3 78.6   0.8 0.024 
AGAP004981-PA PPO4 78.5   0.84 0.357 
AGAP004977-PA PPO6 79   1.06 0.827 
AGAP004980-PA PPO7 79.6   3.66 0.414 
AGAP004976-PA PPO8 79.3   1.03 0.914 
TEP 
AGAP010815-PA TEP1 152.1 21 1 0.4 0.071 
AGAP008654-PA TEP12 96.3   0.32 0.127 
AGAP008368-PA TEP14 139.4   0.17 0.091 
AGAP008364-PA TEP15 163.6 42  0.73 0.045 
AGAP008366-PA TEP2 154.6   1.51 0.021 
AGAP010812-PA TEP4 149.4   1 0.993 
AGAP010814-PA TEP6 151.3 26 1 0.12 0.108 
AGAP010830-PA TEP9 151.5 21 1 0.31 0.537 
PRR 
AGAP007036-PA APL1A 49.4 20  0 0.356 
AGAP007035-PA APL1B 63.9 20  0.74 0.342 
AGAP007033-PA APL1C 82.4 22 1 0.55 0.137 
AGAP004811-PA CTL1 21.8 25 1 0.79 0.402 
AGAP004810-PA CTL3 20.8 22 1 0.72 0.276 
AGAP005335-PA CTL4 19.8 24 1 0.28 0.103 
AGAP003625-PA CTL8 21.5 17  0.99 0.981 
AGAP006430-PB CTLGA2 24.9 17  1.43 0.396 
AGAP010193-PA CTLGA3 27 17  1.02 0.929 
AGAP007412-PA CTLMA1 20.1 24 1 0.57 0.097 
AGAP007411-PA CTLMA3 19.4 21  0.68 0.075 
AGAP002911-PA CTLMA9 17.5 22  0.89 0.939 
AGAP010021-PA Dumpy 172.4   4.71 0.414 
AGAP010024-PA Dumpy 345.1   3.75 0.411 
AGAP003027-PA Dumpy-like protein 43.6 31  1.63 0.31 
AGAP009106-PA GNBP 32.1 26 1 0.53 0.064 
AGAP009110-PA GNBP 42 24  0.52 0.004 
AGAP009146-PA GNBP 33.5 31  0.33 0.084 
AGAP006761-PA GNBPA1 55.7 17 1 0.67 0.176 
AGAP004455-PA GNBPB1 44.1 24  0.75 0.338 
AGAP002798-PA GNBPB2 43.7 19  1.07 0.829 
AGAP002799-PA GNBPB3 43.1 18  146.34 0.356 
AGAP002796-PA GNBPB4 46.7  1 1.63 0.232 
AGAP006327-PA LRIM (Short) 39.6 28  0.71 0.095 
AGAP006348-PA LRIM1 57.3 22  0.56 0.138 
AGAP005693-PA LRIM17 48.8 21  0.63 0.081 
AGAP007039-PA LRIM4 59.9 24  0.46 0.172 
AGAP006644-PA LRR 77 25 1 0.5 0.359 
AGAP011503-PA LRR 32 23  0.79 0.392 
AGAP005962-PA LRR shoc-2 90.7 16  0.79 0.242 
AGAP004832-PA LRR-1 117.8  1 0.7 0.03 
AGAP003878-PA LRR-15 63.2 19 1 1.34 0.013 
AGAP007030-PA LRR-7030 115.4 26 1 0 0.356 
AGAP007059-PA LRR-7059 124   0.79 0.106 
AGAP007060-PA LRR-7060 132.9 28 1 0.76 0.251 
AGAP009762-PA Nimrod 141.6 23 1 0.76 0.497 
AGAP001212-PB PGRPLB 23.3  1 2.24 0.04 
AGAP000536-PA PGRPS1 22.4 26  0.58 0.078 
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AGAP006343-PA PGRPS2 20 20  0 0.356 
AGAP006342-PA PGRPS3 20 20  0.98 0.942 
SP 
AGAP001198-PA Chymotrypsin 29.4 18  0 0.078 
AGAP011608-PA Chymotrypsin BI 36.4 22 2 1.38 0.417 
AGAP001365-PA Chymotrypsin-c-like isoform x1 68.6 21 1 0.68 0.149 
AGAP005663-PA Chymotrypsin-like protease 33.8 34 1 0.61 0.026 
AGAP005670-PA Chymotrypsin-like protease 32.2 16  0.74 0.277 
AGAP005671-PA Chymotrypsin-like protease 32.2 16  0.92 0.709 
AGAP005686-PA Chymotrypsin-like protease 31.9 18  0.98 0.95 
AGAP007252-PA Chymotrypsin-like protease 32.9 17  0.74 0.266 
AGAP009121-PA Chymotrypsin-like protease 27.7 16  0.93 0.785 
AGAP005687-PA Chymotrypsin-like protease 32.1 18  1.01 0.968 
AGAP006674-PA Chymotrypsin-like protease 32.4 21  0.86 0.444 
AGAP006675-PA Chymotrypsin-like protease 32.1 17  0.41 0.214 
AGAP003686-PA CLIP 39.8   0.83 0.315 
AGAP003251-PA CLIPB1 40.9 25  0.5 0.004 
AGAP009214-PA CLIPB11 39.8 25 1 0.95 0.824 
AGAP004855-PA CLIPB13 44.8 22  0.74 0.036 
AGAP009844-PA CLIPB15 40.6 22  0.82 0.182 
AGAP003246-PA CLIPB2 38.4 19  0.35 0.078 
AGAP003249-PA CLIPB3 40.1 30  0.68 0.087 
AGAP003250-PA CLIPB4 39.4 24  0.7 0.076 
AGAP004148-PA CLIPB5 41.3 30  1.02 0.891 
AGAP003057-PA CLIPB8 44.8 24 1 0.52 0.048 
AGAP013442-PB CLIPB9 82.9 26 1 0.67 0.054 
AGAP008835-PA CLIPC1 42.6 25  0.83 0.182 
AGAP000572-PA CLIPC10 40.9 27 1 0.96 0.821 
AGAP004317-PA CLIPC2 41.5 27  0.8 0.346 
AGAP004318-PA CLIPC3 43.1 32 1 0.87 0.296 
AGAP000573-PB CLIPC4 39.4 22  0.79 0.086 
AGAP000315-PA CLIPC6 39.6 22 1 0.81 0.316 
AGAP004719-PA CLIPC9 40.6  1 0.87 0.354 
AGAP002422-PA CLIPD1 48.5 21 1 0.94 0.581 
AGAP002813-PA CLIPD6 52.8 19  1.51 0.222 
AGAP001798-PA Clotting factor C (limulus) homolog 72.6 18 1 1.31 0.464 
AGAP005072-PA Coagulation factor X 96.4 14  0.53 0.002 
AGAP003960-PA Coagulation factor XI 64.6 26 1 0.74 0.171 
AGAP012269-PA Coagulation factor XI 72.3 20 1 1.69 0.139 
AGAP013252-PA Coagulation factor XI 66.6 26  0.94 0.398 
AGAP001245-PA Eupolytin 28.7 16  0.74 0.326 
AGAP001246-PA Eupolytin 30.3 26 1 1.14 0.792 
AGAP001248-PA Eupolytin 28.9 24  1.12 0.814 
AGAP001249-PA Eupolytin 27.1 16  0.89 0.666 
AGAP006539-PA Eupolytin 28.8 18 1 1.54 0.369 
AGAP011920-PA Eupolytin 26.3 18  0.53 0.11 
AGAP012946-PA Plasminogen 35.5 24  0.81 0.359 
AGAP013221-PA Plasminogen 35 24  0.63 0.085 
AGAP006486-PA Prss3 30.8 22 1 0.9 0.817 
AGAP004566-PA Serine protease 35.7 20  0.95 0.837 
AGAP006673-PA Serine protease 33.1 19  0.88 0.535 
AGAP002543-PA Serine protease 29.8 23  0 0.142 
AGAP011917-PA Serine protease 26.2 20 1 0.89 0.812 
AGAP001240-PA Serine protease (thymus-specific) 55.8 16  1.69 0.219 
AGAP005914-PA Serine protease (thymus-specific) 57  1 1.33 0.372 
AGAP012328-PA Serine protease 14 36.5   0.77 0.636 
AGAP012614-PA Serine protease 14 43.4   1.55 0.261 
AGAP013487-PA Serine protease 14 homolog 34.2 29  1.44 0.331 
AGAP005625-PA Serine Protease with SR-A 146.8  1 1.03 0.903 
AGAP010240-PA Trypsin (late) 28.2 17  0.59 0.063 
AGAP006485-PA Trypsin-alpha 30.5 19  0.91 0.858 
AGAP011427-PA Trypsin-like protein 96.2   0.39 0.061 
AGAP012022-PA Trypsin-like protein 97 18  1.41 0.146 
AGAP012504-PA Trypsin-like protein 93.9   1.28 0.283 
AGAP027981-PA Trypsin-like protein 98   1.91 0.09 




AGAP005642-PA Chymotrypsin-like protease 33 26 1 0.97 0.916 
AGAP011791-PA CLIPA1 homolog 48.4 20  0.58 0.112 
AGAP011781-PA CLIPA12 homolog 40.9 25  0.88 0.458 
AGAP011788-PA CLIPA14 homolog 30.4 21  0.87 0.34 
AGAP011790-PB CLIPA2 homolog 55.9 20  0.82 0.508 
AGAP011780-PA CLIPA4 homolog 45.9 20  0.84 0.473 
AGAP011789-PA CLIPA6 homolog 45.7 24  0.93 0.561 
AGAP011792-PA CLIPA7 homolog 80.9 21  0.52 0.011 
AGAP010731-PA CLIPA8 homolog 40.9 25  0.7 0.248 
AGAP013184-PA CLIPB36 homolog 42.5  1 0.9 0.573 
AGAP002270-PA CLIPB7 homolog 43.6 19  1.12 0.741 
AGAP003689-PA CLIPC7 homolog 67 24 1 0.94 0.695 
AGAP008808-PA Coagulation factor XI 67.5   1.02 0.784 
AGAP011919-PA Eupolytin-like 28.1 20  0.55 0.401 
AGAP010730-PA PPO activating factor homolog 28.2   0.69 0.072 
AGAP005707-PA Serine collagenase 1 homolog 32.3 21  0.54 0.201 
AGAP005709-PA Serine collagenase 1 homolog 28.7 17  0.88 0.864 
AGAP006676-PA Serine collagenase 1 homolog 28.6 16  1.09 0.719 
AGAP004740-PA Serine collagenase 1 homolog 27.8 19  0.71 0.489 
AGAP005703-PA Serine collagenase 1 homolog 31.4 21  0 0.356 
AGAP005708-PA Serine collagenase 1 homolog 29.6 23 1 0 0.165 
AGAP003248-PA Serine protease 14 like 33.2 26 1 1.02 0.986 
AGAP004638-PA Serine protease homolog 37.3 30 1 0.79 0.41 
AGAP009216-PA Serine protease homolog 33.9 16  0 0.356 
AGAP013117-PA Serine protease homolog 33.5 19 1 0.64 0.105 
AGAP000290-PA Serine protease homolog 54 25 1 1.07 0.938 
AGAP003691-PA Serine protease homolog 94.4  1 0.54 0.088 
AGAP011325-PA Serine protease homolog 34.2   0.76 0.131 
AGAP001708-PA Serine protease homolog gd-like 30.9 23  0.82 0.44 
AGAP001979-PA Serine protease homolog with SR-A 226  1 2.21 0.422 
AGAP006677-PA Trypsin (late) homolog 29.6 18 1 1.01 0.969 
AGAP009122-PA Trypsin II-P29 like 29.2 21  1.62 0.084 
AGAP006487-PA Trypsin-alpha like 30.4 19  0.97 0.945 
AGAP012505-PA Trypsin-like protein 31.5   24.8 0.356 
AGAP008403-PA Trypsin-like protein 99.3   0.87 0.593 
AGAP013164-PA Trypsin-like protein 28.2 25  1.18 0.659 
AGAP003626-PA Vitamin k-dependent protein c 34.5 23  0.71 0.215 
Serpin 
AGAP006909-PA SRPN1 47.7 26  1.56 0.234 
AGAP005246-PD SRPN10B 42.6   1.93 0.044 
AGAP005246-PE SRPN10D 42.2   124.84 0.356 
AGAP001377-PA SRPN11 57.1 16  1.04 0.905 
AGAP001375-PA SRPN12 64.8 15  1.39 0.467 
AGAP009213-PA SRPN16 61.1 28  0.78 0.314 
AGAP001376-PA SRPN17 53.7 35 1 1.01 0.939 
AGAP006911-PA SRPN2 46.5 21  0.79 0.199 
AGAP006910-PA SRPN3 47.1 22  1.18 0.373 
AGAP009670-PA SRPN4 68.9 25 1 0.86 0.596 
AGAP009670-PB SRPN4 61.8 25 1 0.8 0.314 
AGAP007693-PA SRPN7 44.3 25  0.95 0.792 
AGAP003194-PA SRPN8 48.8 20  0.88 0.383 
AGAP003139-PA SRPN9 50.4 28  1.26 0.365 
AGAP006813-PA TIL domain-containing protein 13.4 22  1.5 0.377 
Other 
AGAP002585-PA Cell wall cysteine-rich protein 175.6  1 2.35 0.34 
AGAP004631-PA Coagulation factor deficiency 2 homolog 26.1 21  1.4 0.553 
AGAP003987-PA Complement component 1 Q binding protein 29.6   0.48 0.209 
AGAP002878-PA Cystatin-like protein 11   1.08 0.49 
AGAP011460-PA Cysteine-rich protein (salivary) 11.2 20  0.39 0.11 
AGAP006253-PA Cysteine-rich venom protein 9.5 20  1.14 0.761 
AGAP012970-PA Cysteine-rich venom protein 8.8 18  0.64 0.45 
AGAP011832-PA Death-associated protein 1 10.3   0.6 0.395 
AGAP008878-PA Defense protein 17.7 21 1 0.93 0.799 
AGAP010884-PA Down syndrome cell adhesion molecule A 214.7   0.47 0.645 
AGAP000025-PA E3 SUMO-protein ligase 2 150.4   0 0.356 
AGAP002982-PA E3 SUMO-protein ligase RanBP2 308.1   2 0.021 
AGAP010822-PA Fasciclin 26.3   0.93 0.749 
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AGAP010823-PA Fasciclin isoform c 52.4 23 1 0 0.356 
AGAP011239-PA FBN7 30.4   0.81 0.468 
AGAP009184-PA FBN8 35.9 22  0.49 0.146 
AGAP010775-PA FBN8 23.3   0 0.356 
AGAP011223-PA FBN8 24.8   0.53 0.067 
AGAP011225-PA FBN8 34.5 22  0.52 0.084 
AGAP009556-PA FBN8 22.4 18  0.76 0.161 
AGAP004918-PA Fibrinogen 35 19  1.03 0.835 
AGAP004996-PA Fibrinogen 46.8 19  0.7 0.609 
AGAP006743-PA Fibrinogen 37.4   0.79 0.042 
AGAP006790-PA Fibrinogen 30.8   0.29 0.165 
AGAP011197-PA Fibrinogen 32.3   0.98 0.941 
AGAP004917-PA Fibrinogen-related protein 1 34.2 21  0.83 0.251 
AGAP006914-PA Fibrinogen-related protein 1 31.3 18  0.84 0.343 
AGAP008797-PA Immunoglobulin (CD79A) binding protein 1 42.2   14.42 0.356 
AGAP000032-PA Integrin alpha-ps2 isoform x1 166.7 41 1 1.36 0.279 
AGAP008968-PA Kazal domain-containing protein 6.5 18  0.88 0.757 
AGAP011482-PA Kazal domain-containing protein 8.5 22 1 1.25 0.514 
AGAP007629-PB Laminin gamma 1 179.6 28 1 1.01 0.965 
AGAP004993-PA Laminin subunit alpha 412.1 23  0.76 0.207 
AGAP002857-PB MDL2 18.1 25 1 0.5 0.02 
AGAP011319-PA Pacifastin-related peptide 25.3 17  0.73 0.105 
AGAP008804-PB Peroxin-19 33.2   0.36 0.25 
AGAP001325-PA Peroxiredoxin 5, atypical 2-Cys peroxiredoxin 20.6   0.85 0.438 
AGAP004674-PA Phenoloxidase inhibitor protein 36.3 21  0.92 0.727 
AGAP010477-PB Phosducin-like 3 26.3   1.25 0.179 
AGAP005531-PA Programmed cell death 6-interacting protein 94.1   1.26 0.091 
AGAP000378-PA Programmed cell death protein 4 47.4   1.15 0.857 
AGAP005432-PA Programmed cell death protein 5 14.8   1.23 0.642 
AGAP003476-PA Protein BCP1 33.6   0.93 0.772 
AGAP004333-PA Serine-type endopeptidase inhibitor 173.7   0.27 0.125 
AGAP003012-PA SP71 isoform A 78.6 25 1 1.42 0.61 
AGAP000305-PA SPARC 22.2   1.16 0.579 
AGAP011765-PA Spondin-1 87 31  0.81 0.403 
AGAP003338-PA Thioredoxin 15.5   0.32 0.384 
AGAP007201-PA Thioredoxin 15.6   1.27 0.468 
AGAP009584-PA Thioredoxin 12.1   0.64 0.119 
AGAP000396-PA Thioredoxin peroxidase 26   0.82 0.433 
AGAP011054-PA Thioredoxin peroxidase 22   1.09 0.209 
AGAP011824-PA Thioredoxin peroxidase 25   0.95 0.703 
AGAP005462-PA Thioredoxin-like protein 1 31.6   0.89 0.528 
AGAP001613-PA Thioredoxin-related transmembrane protein 1 38.9 22 1 1.38 0.455 
AGAP003615-PA Toll-interacting protein 30.4   1.42 0.516 
*SP indicates the predicted signal peptide cleavage site, and TMs indicates the predicted number of transmembrane domains.  
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Slice 1 2 3 4 5 6 7 8 9 10 11 12 





0.9 CH 0 0 0 0 0 44 24 16 3 0 14 0 




1.2 CH 0 4 0 0 28 14 12 16 4 5 5 13 
10.8 IH 0 0 0 0 9 7 5 47 17 5 7 3 
AGAP002982-PA 
E3 SUMO-protein 
ligase RanBP2  
308.1 
0.5 CH 0 0 0 0 0 0 0 60 40 0 0 0 






0.1 CH 0 0 0 0 0 0 0 32 23 46 0 0 
0.5 IH 0 0 0 0 0 0 0 35 6 46 13 0 
AGAP007629-PB 
Laminin gamma 1 
179.6 
0.2 CH 0 0 0 0 0 0 47 21 32 0 0 0 





0.1 CH 0 0 0 0 0 0 0 0 100 0 0 0 






0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




0.8 CH 0 0 0 0 0 14 12 31 20 10 12 0 





0.8 CH 0 0 0 0 0 0 0 3 31 18 48 0 





0 CH 0 0 0 0 0 0 0 0 0 0 0 100 




40.2 CH 0 0 0 0 0 0 11 47 16 15 8 3 





2.3 CH 0 0 0 13 11 17 15 40 2 3 0 0 





1.2 CH 0 0 0 0 0 0 0 39 19 0 42 0 




0.5 CH 0 0 0 0 0 5 10 70 15 0 0 0 




0.2 CH 0 0 0 0 0 0 0 71 29 0 0 0 
0.2 IH 0 0 0 0 0 0 0 40 60 0 0 0 
AGAP001798-PA 
Clotting factor C 
(limulus) homolog 
72.6 
0 CH 0 0 0 0 0 0 0 0 0 0 0 0 
0.1 IH 0 0 0 0 0 0 0 0 0 0 100 0 









0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




18.6 CH 3 3 1 2 4 6 4 10 5 8 5 50 




0.4 CH 0 0 0 0 0 0 0 34 7 0 0 59 
0.6 IH 0 0 0 0 0 0 0 5 0 0 0 95 
AGAP012328-PA 
Serine protease 14 
36.5 
0.9 CH 0 0 0 0 0 0 0 10 0 0 0 90 





176.4 CH 0 0 0 0 1 0 0 2 5 7 49 34 





5.5 CH 3 2 0 3 4 0 1 3 8 57 17 3 




0.1 CH 0 0 0 0 0 0 0 82 18 0 0 0 




0.4 CH 0 0 0 0 0 0 5 0 19 0 69 7 





207.9 CH 0 0 0 0 0 0 0 1 4 19 63 14 




23 CH 0 0 0 0 4 0 1 3 6 5 9 71 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





0.2 CH 0 0 0 0 0 0 0 0 100 0 0 0 
0.4 IH 0 0 0 0 0 0 0 0 100 0 0 0 
*RA stands for relative abundance, it’s represented as [protein abundance * 10000/total protein abundance of CH or IH]. Molecular 
weight under each gel slice indicates the upper limit of each slice. The values of each protein in each slice is the percentage of abundance 
out of the protein’s total abundance in CH or IH, so 12 slices of each protein adds up to 100%. Red boxes indicate the calculated 
positions of the proteins.  
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Slice 1 2 3 4 5 6 7 8 9 10 11 12 




3.6 CH 0 3 0 8 5 13 24 33 9 0 2 3 




2.2 CH 0 4 7 8 12 18 14 16 4 0 5 12 




157.2 CH 3 3 4 5 11 14 28 29 2 0 1 1 




106.5 CH 7 10 6 18 13 10 28 3 1 0 1 1 




3.2 CH 0 0 0 14 10 20 28 29 0 0 0 0 




40.8 CH 5 4 4 7 7 10 18 20 19 2 2 3 




142 CH 3 3 4 8 7 19 25 24 2 0 1 3 




88 CH 5 5 4 9 6 9 12 29 8 4 5 7 




23.2 CH 5 5 4 11 12 10 13 31 3 2 4 1 




5 CH 8 7 6 10 7 10 15 8 5 0 19 4 




29 CH 2 3 3 6 8 15 23 33 2 2 2 1 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




4.2 CH 4 3 1 7 9 9 11 19 7 7 5 19 




9.3 CH 6 8 2 10 7 11 6 15 4 1 4 25 




8.6 CH 6 5 6 9 14 13 21 25 0 0 0 0 




1.8 CH 0 4 17 16 36 23 4 0 0 0 0 0 




11.2 CH 7 7 9 6 12 15 16 6 9 6 4 4 




12.1 CH 4 5 2 6 10 12 8 29 10 2 3 9 




396.3 CH 7 6 7 10 9 15 10 13 4 7 5 8 




1.5 CH 0 0 0 7 9 4 8 55 4 0 1 11 
0.4 IH 0 0 0 16 0 35 5 45 0 0 0 0 
*Relative abundance is represented as [protein abundance * 10000/total protein abundance of CH or IH]. Molecular weight under each 
gel slice indicates the upper limit of each slice. The values of each protein in each slice is the percentage of abundance out of the 
protein’s total abundance in CH or IH, so 12 slices of each protein adds up to 100%. Red boxes indicate the calculated positions of the 
proteins.   
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Slice 1 2 3 4 5 6 7 8 9 10 11 12 




0.2 CH 58 34 0 0 8 0 0 0 0 0 0 0 




0.2 CH 0 100 0 0 0 0 0 0 0 0 0 0 




1.3 CH 30 0 45 0 0 0 11 9 5 0 0 0 




0.2 CH 38 53 0 8 0 0 0 0 0 0 0 0 




241.6 CH 17 30 22 22 6 2 1 0 0 0 0 0 




387.9 CH 13 27 18 31 4 2 2 1 1 0 0 0 




49.8 CH 17 28 21 28 4 1 1 0 0 0 0 0 




6 CH 18 28 18 12 17 1 4 2 0 0 0 0 




1.1 CH 14 25 12 14 20 0 0 8 0 0 7 0 




0.3 CH 0 31 0 32 37 0 0 0 0 0 0 0 




3 CH 29 33 15 9 5 2 4 1 1 0 0 0 





35.4 CH 13 24 16 13 21 6 3 2 1 0 0 2 




2.9 CH 10 19 9 13 23 2 8 9 5 0 0 0 




2.6 CH 11 23 22 22 21 0 0 0 0 0 0 0 




0.1 CH 0 0 61 39 0 0 0 0 0 0 0 0 




7 CH 6 12 15 16 8 20 10 5 4 4 0 0 




28.8 CH 5 14 19 22 14 13 4 3 4 0 2 1 




45.9 CH 11 11 25 12 10 16 5 3 2 0 1 4 
57.6 IH 12 13 31 11 9 9 4 3 2 2 1 5 
AGAP003012-PA 
SP71 isoform A 
78.6 
1531.9 CH 7 9 21 10 8 24 6 4 3 3 3 2 




33.4 CH 7 9 19 10 9 19 8 5 4 4 5 3 




907.4 CH 11 10 17 9 8 21 6 4 3 3 5 3 
826.7 IH 12 12 18 11 7 14 5 4 3 4 6 4 
AGAP012269-PA 
Coagulation factor XI 
72.3 
0 CH 0 100 0 0 0 0 0 0 0 0 0 0 
0.1 IH 0 100 0 0 0 0 0 0 0 0 0 0 
AGAP008808-PA 
Coagulation factor XI 
67.5 
0.3 CH 0 0 0 100 0 0 0 0 0 0 0 0 
1 IH 72 0 28 0 0 0 0 0 0 0 0 0 
AGAP013252-PA 
Coagulation factor XI 
66.6 
6.8 CH 9 7 18 13 13 17 9 5 4 0 4 2 
8 IH 9 10 27 12 11 8 6 4 3 3 6 3 
AGAP003960-PA 
Coagulation factor XI 
64.6 
21.8 CH 17 16 14 18 13 4 11 3 3 0 0 1 




0.8 CH 0 0 0 46 14 9 30 0 0 0 0 0 




0.2 CH 0 12 0 64 24 0 0 0 0 0 0 0 




0.9 CH 0 25 0 29 45 0 0 0 0 0 0 0 
0.6 IH 0 0 0 52 48 0 0 0 0 0 0 0 
*Relative abundance is represented as [protein abundance * 10000/total protein abundance of CH or IH]. Molecular weight under each 
gel slice indicates the upper limit of each slice. The values of each protein in each slice is the percentage of abundance out of the 
protein’s total abundance in CH or IH, so 12 slices of each protein adds up to 100%. Red boxes indicate the calculated positions of the 




Figure 1. Gel cutting and proteins identified in each gel slice. (A) shows representative lanes of 
CH and IH. 40 µg total protein of each biological replicate was loaded to each lane and 
electrophoresed in 4-15% gradient gel. After staining and destaining, each lane was divided into 12 
slices, with the molecular mass range of 500-350, 350-250, 250-230, 230-140, 140-80, 80-70, 70-
45, 45-30, 30-22, 22-20, 20-15, 15-0kDa respectively. (B) shows the number of proteins identified 
(LFQ intensity not zero) in each gel slice of CH and IH. CH: 583, 674, 544, 806, 765, 817, 1023, 
1197, 1189, 781, 981, 958 proteins from slice 1 to 12. IH: 687, 744, 698, 859, 742, 864, 1061, 1206, 





Figure 2. Composition of total and immunity-related proteins. The total 1756 proteins are 
grouped into 9 categories and their numbers are indicated in (A). The 235 immunity-related proteins 
are grouped into 6 categories and their numbers are indicated in (B). 
 
 
Figure 3. Distribution of protein number and abundance. (A) Distribution of protein numbers 
within each LFQ range. (B) shows the relative abundance of all proteins within each LFQ range. 




Figure 4. Correlation between protein abundance and slices presented. Correlation between 
protein abundance and the number of gel slices the protein is presented are indicated in (A) for CH 
and (B) for IH, respectively. Protein abundance is represented as the logarithm of LFQ intensity 
with base 2. The number of proteins within each group is indicated above each dot line. 
 
Figure 5. Western blot of hemolymph samples using monoclonal antibodies. Purified 
recombinant PPO2 and PPO7 (400 ng), and 7 μg total hemolymph protein of A. gambiae larva, 
pupa, adult were used. Membranes were blocked with 3% BSA in TBS, probed with the primary 
antibodies (1P5, 3P35, or AaPPO5 at 1ng/μl) and secondarily with GAM-AP (for 1P5 or 3P35) or 
GAR-AP (for AaPPO5) at 1:1000 dilution. Antibodies are all in 1% BSA containing TBS, and 
3P35 antibody was always pre-mixed with BSA for 1 h to eliminate its cross-reactivity with BSA 




Figure 6. RNA knockdown efficiency at mRNA and protein level. (A) Total RNA was isolated 
from 5 female mosquitoes at 24 h after dsRNA injection. Then reverse transcription was performed 
to generate first strand cDNA, and mRNA level of each PPO gene was examined by qPCR using 
specific primers (Table 2, Appendices). PPO6 is omitted because of non-pure melting curves. (B) 
Hemolymph of 15 female mosquitoes was extracted 4 days post dsRNA injection. 3ug total protein 
was used for western blot analysis with anti- Aedes aegypti PPO5 primary antibody (1:1000) and 
GAR-AP secondary antibody (1:1000). PPO is around 80 kDa, and the lower band is probably PO 





Figure 7. Mosquito survival upon E. coli infection after PPO knockdown. A. gambiae female 
adults within 1-2 days after emergence were injected with dsRNA targeting PPO or GFP (control). 
Then a 4-day interval was allowed for full recovery of mosquitoes before E. coli challenge was 
introduced. Survival rate was recorded for the following 7 days with dead individuals daily counted 
and removed. Brown dots represent dsPPO injected mosquitoes, and blue dots represent dsGFP. 
Result here is a summary of three independent replicates, each carried out with ~40 female 
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Table 1. Primers for qRT-PCR targeting PPO genes 
Primers Sequences 
Actin-F* 5’- CACACCGTCCCAATCTATGAAGGTTATG -3’ 
Actin-R 5’- CTTCTCCTTGATGTCACGGACAATTTCAC -3’ 
AgPPO1-F 5’- AAGAACAAGCTGCCACCGTACA -3’ 
AgPPO1-R 5’- CAGATGGGTGAACCTTGCAAACAC -3’ 
AgPPO2-F 5’- ACAAAGATGCGCTGGCTCAGTT -3’ 
AgPPO2-R 5’- ACGGTGCGTTAGGGTCAAGTTC -3’ 
AgPPO3-F 5’- CACCGTTAACCTAAACCCTGGTACG -3’ 
AgPPO3-R 5’- CGTGCTTGGCTCGTTGATGTTAGA -3’ 
AgPPO4-F 5’- CGTCACACTTAATGCCGGTGCTAAT -3’ 
AgPPO4-R 5’- TTCGGCCAACCACAGTTACAGAAC -3’ 
AgPPO5-F 5’- GCCTACACAAGCTCGGAACTTTCA -3’ 
AgPPO5-R 5’- TCGAACTGTGATCGCTGCCAAA -3’ 
AgPPO6-F 5’- TCGTAAACAATCAAAGGGATCGGATCACAA -3’ 
AgPPO6-R 5’- GCTCACCACGGCGATCCTTATT -3’ 
AgPPO7-F 5’- GTGAATTTAACACCTGGCATTAACAACATC -3’ 
AgPPO7-R 5’- GCAGAAGCGGAAATTTGCATCAC -3’ 
AgPPO8-F 5’- TACGATGAGAATGCTGGGTGCGAT -3’ 
AgPPO8-R 5’- GTCACAGTCGCCAATCGCATGTTT -3’ 
AgPPO9-F 5’- CGTCAAGTTACATCCTGGCGATAA -3’ 
AgPPO9-R 5’- ACAGATCGAACGGTTGACCATC -3’ 
*F for forward primer and R for reverse primer.  
54 
 
Table 2. Peptides for PPO monoclonal antibody generation 
Proteins Epitope sequences Proteins Epitope sequences 
PPO2 ELLTPYTAEQLGNPG Common* QSSVTIPYERTFRN 
PPO2 TAEQLGNPGVTVNSV Common KDRRGELFYYMHQQL 
PPO2 SVGVQLSRPNTPANV Common LLTFWQRSQVDLGTG 
PPO2 VEVNNESGAVRKGTL PPO6 SSEADTRIAVRATTL 
PPO2 AIGTKSAPTDKDALA PPO6 EGAVVNNQRDRITID 
PPO2 TDFEQDSVAQELDPN PPO6 NANQIGYAGVQIQSF 
PPO2 TLADFVTPNSNMKTA PPO6 MALSNINLPETEQFR 
PPO2 NSNMKTATVQVKFNN PPO6 SDFTRPNSNMTNIEV 
PPO8 GPNSPASSQVSNDTG PPO7 SAAAAAPAGTSADTP 
PPO8 SNDTGVPPTVVTIKD PPO7 DTPTMNRVSLNNIPD 
PPO8 AGFAVSDDGVRVPLD PPO7 VSLNNIPDPDIKFAE 
PPO8 TMAELSNSNVTLEAL PPO7 NPGVNLLSLETELDR 
PPO8 ETQLDRAGGAVNSFV PPO7 LETELDRRDSVKNTL 
PPO8 LRINSTARSNRQDTV PPO7 LQVAYSGTAKPATLR 
PPO8 GNVEQANAGNAQSRF PPO7 TFRNVANTNIGDANF 
PPO8 FEDDNANVNYDENAG PPO7 HEQDRVNPLFDERTD 
*Common for consensus regions of PPO proteins. 
 





Slice 1 2 3 4 5 6 7 8 9 10 11 12 





0.9 CH 0 0 0 0 0 44 24 16 3 0 14 0 




1.2 CH 0 4 0 0 28 14 12 16 4 5 5 13 
10.8 IH 0 0 0 0 9 7 5 47 17 5 7 3 
AGAP002982-PA 
E3 SUMO-protein 
ligase RanBP2  
308.1 
0.5 CH 0 0 0 0 0 0 0 60 40 0 0 0 






0.1 CH 0 0 0 0 0 0 0 32 23 46 0 0 






0.7 CH 0 100 0 0 0 0 0 0 0 0 0 0 
0 IH 0 0 0 0 0 0 0 0 0 0 0 0 
AGAP007629-PB 
Laminin gamma 1 
179.6 
0.2 CH 0 0 0 0 0 0 47 21 32 0 0 0 





0.1 CH 0 0 0 0 0 0 0 0 100 0 0 0 






0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




0.8 CH 0 0 0 0 0 14 12 31 20 10 12 0 





0.8 CH 0 0 0 0 0 0 0 3 31 18 48 0 
1.5 IH 0 0 0 0 0 0 0 0 27 32 41 0 









0.2 CH 58 34 0 0 8 0 0 0 0 0 0 0 




60.3 CH 18 16 20 16 16 6 2 1 2 0 1 2 




0.2 CH 0 100 0 0 0 0 0 0 0 0 0 0 




1.3 CH 30 0 45 0 0 0 11 9 5 0 0 0 





0 CH 0 0 0 0 0 0 0 0 0 0 0 100 




16.3 CH 15 13 28 9 19 11 2 1 0 0 0 1 





8.5 CH 4 6 5 11 9 3 8 20 10 3 9 12 




40.2 CH 0 0 0 0 0 0 11 47 16 15 8 3 




0.2 CH 38 53 0 8 0 0 0 0 0 0 0 0 




241.6 CH 17 30 22 22 6 2 1 0 0 0 0 0 




387.9 CH 13 27 18 31 4 2 2 1 1 0 0 0 




49.8 CH 17 28 21 28 4 1 1 0 0 0 0 0 




0 CH 0 0 0 100 0 0 0 0 0 0 0 0 





6 CH 18 28 18 12 17 1 4 2 0 0 0 0 





1.1 CH 14 25 12 14 20 0 0 8 0 0 7 0 





0.3 CH 0 31 0 32 37 0 0 0 0 0 0 0 





2.3 CH 0 0 0 13 11 17 15 40 2 3 0 0 




3 CH 29 33 15 9 5 2 4 1 1 0 0 0 





1.2 CH 0 0 0 0 0 0 0 39 19 0 42 0 





35.4 CH 13 24 16 13 21 6 3 2 1 0 0 2 






0.6 CH 0 7 0 32 61 0 0 0 0 0 0 0 





2.9 CH 10 19 9 13 23 2 8 9 5 0 0 0 




2.6 CH 11 23 22 22 21 0 0 0 0 0 0 0 




12.9 CH 10 11 7 6 10 6 7 9 7 10 9 7 




31.3 CH 5 4 2 5 5 6 6 24 5 25 9 5 




103.6 CH 7 9 14 9 15 13 3 3 5 8 8 6 




99.4 CH 8 10 10 11 18 7 8 7 10 4 4 3 






0.1 CH 0 0 61 39 0 0 0 0 0 0 0 0 




7 CH 6 12 15 16 8 20 10 5 4 4 0 0 




28.8 CH 5 14 19 22 14 13 4 3 4 0 2 1 




45.9 CH 11 11 25 12 10 16 5 3 2 0 1 4 




0.5 CH 0 0 0 0 0 5 10 70 15 0 0 0 
1.2 IH 8 9 0 7 0 1 8 46 8 5 3 5 
AGAP003012-PA 
SP71 isoform A 
78.6 
1531.9 CH 7 9 21 10 8 24 6 4 3 3 3 2 




33.4 CH 7 9 19 10 9 19 8 5 4 4 5 3 




907.4 CH 11 10 17 9 8 21 6 4 3 3 5 3 




0.2 CH 0 0 0 0 0 0 0 71 29 0 0 0 
0.2 IH 0 0 0 0 0 0 0 40 60 0 0 0 
AGAP001798-PA 
Clotting factor C 
(limulus) homlog 
72.6 
0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





0 CH 0 100 0 0 0 0 0 0 0 0 0 0 





278.7 CH 9 9 16 10 13 18 11 5 4 1 2 3 




22 CH 4 4 2 10 8 6 24 17 4 2 2 17 
24.6 IH 4 5 3 11 7 5 21 24 4 1 1 14 
AGAP001365-PA 
Chymotrypsin-c-
like isoform x1 
68.6 
1.2 CH 0 0 0 14 13 13 10 33 18 0 0 0 





0.3 CH 0 0 0 100 0 0 0 0 0 0 0 0 




18 CH 7 11 10 12 7 15 16 16 2 0 2 2 





6.8 CH 9 7 18 13 13 17 9 5 4 0 4 2 




103.6 CH 0 0 0 1 1 1 2 7 16 31 37 4 





21.8 CH 17 16 14 18 13 4 11 3 3 0 0 1 




0.8 CH 0 0 0 46 14 9 30 0 0 0 0 0 




3.5 CH 3 6 6 10 6 22 37 9 0 0 0 0 




111.1 CH 2 2 3 4 7 4 23 7 4 5 9 30 




109.7 CH 3 4 4 8 8 7 18 5 3 6 18 15 






0.8 CH 0 6 18 18 21 17 20 0 0 0 0 0 




10.9 CH 12 11 14 16 15 8 10 7 6 0 1 0 




125.4 CH 7 7 6 11 16 8 25 5 4 2 5 3 




164.1 CH 3 4 4 7 8 7 38 15 6 3 2 2 





1.2 CH 0 7 0 31 14 15 34 0 0 0 0 0 






62.7 CH 2 3 4 3 13 14 8 10 5 6 19 12 





1.1 CH 27 33 20 16 3 0 0 0 0 0 0 0 




0.2 CH 0 12 0 64 24 0 0 0 0 0 0 0 





0.1 CH 0 0 0 0 0 0 0 70 30 0 0 0 




3.6 CH 0 3 0 8 5 13 24 33 9 0 2 3 




2.2 CH 0 4 7 8 12 18 14 16 4 0 5 12 
3.2 IH 3 7 13 8 13 7 15 16 3 4 2 9 
AGAP010823-PA 
Fasciclin isoform c 
52.4 
0.1 CH 0 0 0 0 0 0 0 100 0 0 0 0 




157.2 CH 3 3 4 5 11 14 28 29 2 0 1 1 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




5.5 CH 7 6 7 11 16 14 31 5 2 0 0 2 




106.5 CH 7 10 6 18 13 10 28 3 1 0 1 1 




3.2 CH 8 7 4 9 17 9 12 14 0 0 13 6 




36.8 CH 6 6 7 10 11 8 21 8 3 2 11 8 




3.2 CH 0 0 0 14 10 20 28 29 0 0 0 0 
4 IH 4 8 0 11 5 15 40 17 0 0 0 0 
AGAP000378-PA 
Programmed cell 
death protein 4  
47.4 
1.2 CH 0 7 4 11 22 6 12 28 11 0 0 0 




40.8 CH 5 4 4 7 7 10 18 20 19 2 2 3 




3.5 CH 5 3 0 5 9 6 21 9 3 3 4 31 




0.8 CH 8 11 7 23 28 0 0 24 0 0 0 0 




142 CH 3 3 4 8 7 19 25 24 2 0 1 3 




87.7 CH 5 4 4 6 7 6 19 10 9 15 7 7 




315 CH 6 6 5 9 9 7 18 22 10 3 2 4 




17.7 CH 11 9 8 16 16 10 18 6 5 0 0 1 




88 CH 5 5 4 9 6 9 12 29 8 4 5 7 




23.2 CH 5 5 4 11 12 10 13 31 3 2 4 1 




326.2 CH 7 7 5 13 13 9 14 17 3 3 7 2 




13.2 CH 10 10 7 11 12 9 10 21 4 1 1 4 





4.4 CH 0 12 3 14 19 4 8 16 3 0 14 7 




1.5 CH 0 0 0 0 0 0 0 14 21 31 34 0 
2.5 IH 0 0 0 0 0 0 0 16 25 25 30 4 
AGAP012614-PA 
Serine protease 14 
43.4 
6.7 CH 0 0 3 6 3 9 10 53 12 1 1 3 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




6 CH 5 5 4 16 9 8 11 27 7 0 4 3 






5 CH 8 7 6 10 7 10 15 8 5 0 19 4 




29 CH 2 3 3 6 8 15 23 33 2 2 2 1 




1.5 CH 0 0 0 0 0 9 24 25 12 0 19 10 






0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




27 CH 4 3 3 4 6 3 12 4 5 7 17 34 




4.2 CH 4 3 1 7 9 9 11 19 7 7 5 19 




9.3 CH 6 8 2 10 7 11 6 15 4 1 4 25 




10 CH 11 9 7 13 13 9 13 12 12 0 0 0 




18.6 CH 3 3 1 2 4 6 4 10 5 8 5 50 




8.6 CH 6 5 6 9 14 13 21 25 0 0 0 0 




2.2 CH 0 0 0 0 0 3 30 37 13 0 16 0 




4.8 CH 3 5 4 13 8 12 10 29 3 0 1 12 




1.8 CH 0 4 17 16 36 23 4 0 0 0 0 0 




15.4 CH 6 4 5 7 7 8 7 32 8 5 6 6 




11.2 CH 7 7 9 6 12 15 16 6 9 6 4 4 




0.4 CH 0 0 0 0 0 0 0 34 7 0 0 59 




4.6 CH 3 8 4 17 18 14 24 12 0 0 0 0 




8.8 CH 0 0 0 0 0 7 15 28 10 9 14 16 




12.1 CH 4 5 2 6 10 12 8 29 10 2 3 9 




396.3 CH 7 6 7 10 9 15 10 13 4 7 5 8 







0.3 CH 0 0 0 0 0 0 0 16 84 0 0 0 




1.5 CH 0 0 0 7 9 4 8 55 4 0 1 11 




0.9 CH 0 25 0 29 45 0 0 0 0 0 0 0 





19.4 CH 9 7 6 13 6 11 18 15 3 2 3 5 
17 IH 6 7 4 16 6 25 11 8 2 5 3 7 
AGAP012328-PA 
Serine protease 14 
36.5 
0.9 CH 0 0 0 0 0 0 0 10 0 0 0 90 




0.2 CH 0 0 0 0 0 0 23 23 54 0 0 0 





176.4 CH 0 0 0 0 1 0 0 2 5 7 49 34 




41.1 CH 10 8 9 15 13 7 10 20 2 1 3 2 
24.4 IH 11 8 10 18 17 9 6 15 1 2 1 1 









18.1 CH 5 5 4 9 11 7 8 29 5 9 4 4 




7.8 CH 6 5 1 9 8 5 8 38 9 5 5 2 




1.7 CH 2 7 6 16 19 18 7 23 2 0 0 0 




175 CH 5 4 4 7 9 10 11 25 9 5 9 2 






4 CH 10 1 4 11 9 14 15 32 4 0 0 0 





4.4 CH 0 0 0 2 7 7 9 21 10 19 12 12 





5.4 CH 0 3 0 9 5 8 12 53 4 0 3 3 
14 IH 5 4 1 10 7 9 11 40 3 1 2 7 
AGAP013487-PA 
Serine protease 14 
homlog 
34.2 
4.1 CH 2 5 0 10 13 13 15 32 9 0 1 1 





0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





38.4 CH 3 2 2 4 4 4 5 5 32 26 6 6 
29.4 IH 4 3 3 6 4 3 4 7 32 20 7 8 
AGAP003476-PA 
Protein BCP1  
33.6 
1.2 CH 0 0 0 0 0 0 19 54 13 0 14 0 




2.6 CH 6 8 0 13 9 9 14 36 2 0 4 0 





10.3 CH 0 0 0 2 3 1 1 63 9 7 11 0 




0.2 CH 0 0 0 0 0 0 0 100 0 0 0 0 
0.1 IH 0 0 0 0 0 0 0 100 0 0 0 0 
AGAP003248-PA 
Serine protease 14 
like 
33.2 
0.1 CH 0 0 0 0 0 0 0 100 0 0 0 0 




0 CH 0 0 0 0 0 0 0 0 100 0 0 0 





2.6 CH 12 2 0 6 7 4 10 13 12 12 20 2 





2.8 CH 0 0 0 0 0 10 13 18 53 0 2 5 





62.3 CH 4 3 3 7 5 6 9 10 36 5 4 8 




6.7 CH 7 8 4 13 12 5 11 22 15 1 0 1 





5.5 CH 3 2 0 3 4 0 1 3 8 57 17 3 





186.4 CH 6 4 4 7 8 8 8 8 30 7 5 5 





66.9 CH 5 3 4 7 6 7 8 8 32 11 5 4 




0.5 CH 0 0 0 0 0 0 0 34 66 0 0 0 
0.2 IH 0 0 0 0 0 0 34 34 31 0 0 0 











23.6 CH 4 6 3 9 4 5 6 35 8 5 11 4 




1.9 CH 0 0 0 15 13 6 14 31 21 0 0 0 





5.8 CH 6 5 4 11 11 7 11 13 28 1 2 2 





0.9 CH 0 0 0 0 0 0 19 56 17 0 0 8 





0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





0 CH 0 0 0 0 0 0 0 100 0 0 0 0 





4.8 CH 9 12 0 16 13 11 13 13 12 0 0 0 





5.9 CH 0 3 0 5 4 5 9 23 18 8 12 14 




2 CH 8 6 4 21 0 0 13 15 28 0 5 0 




0.1 CH 0 0 0 0 0 0 0 82 18 0 0 0 




39.2 CH 5 5 4 9 9 7 11 38 7 1 3 3 




150.1 CH 8 7 6 10 13 7 11 20 7 6 4 2 





0.1 CH 0 0 0 0 0 0 0 16 84 0 0 0 




31.9 CH 6 5 4 12 8 6 10 11 26 4 2 8 




4.6 CH 14 10 6 12 20 11 8 17 1 0 0 0 




2 CH 0 0 0 11 0 8 9 13 55 2 2 0 




0.1 CH 0 0 0 0 0 0 0 100 0 0 0 0 
0 IH 0 0 0 0 0 0 0 0 0 0 0 0 
AGAP003987-PA 
Complement 
component 1 Q 
binding protein 
29.6 
3.6 CH 0 0 0 0 0 0 4 8 53 7 13 15 





0.4 CH 0 0 0 0 0 0 0 7 7 75 11 0 





1.6 CH 3 2 0 6 7 10 6 9 28 4 17 9 




0.2 CH 0 0 0 0 0 0 0 100 0 0 0 0 
0 IH 0 0 0 0 0 0 0 0 0 0 0 0 
AGAP009122-PA 
Trypsin II-P29 like 
29.2 
2.7 CH 0 4 0 17 4 3 11 10 16 30 2 2 




0.7 CH 0 0 0 14 14 0 0 12 48 0 6 6 




2.6 CH 5 3 4 10 6 9 11 19 25 3 6 0 




16.5 CH 0 2 0 8 0 3 7 12 55 0 0 14 
18.7 IH 2 0 0 10 0 0 3 10 56 0 0 19 











32.7 CH 6 5 5 12 11 7 12 9 24 1 6 2 




24.7 CH 7 10 8 11 17 9 7 13 16 0 1 1 





11 CH 12 6 5 8 6 7 11 7 27 4 5 2 





52.6 CH 6 6 6 11 12 11 15 24 4 1 2 1 




24.3 CH 4 2 2 3 4 3 3 4 40 4 10 21 





2.1 CH 0 0 0 9 0 10 15 17 39 0 1 9 





3.4 CH 0 5 0 17 3 2 13 7 32 0 6 15 




109.4 CH 4 4 3 10 3 8 8 9 25 15 7 4 




12 CH 0 0 0 3 1 1 5 10 72 1 4 4 




41.7 CH 5 4 4 6 5 5 8 8 34 6 4 10 




20.3 CH 5 5 4 7 10 11 12 21 6 3 7 9 




0.4 CH 0 0 0 0 0 0 5 0 19 0 69 7 




0.8 CH 0 0 0 0 0 0 7 13 67 0 0 13 






0.1 CH 0 0 0 0 0 0 0 100 0 0 0 0 





2.1 CH 0 0 0 10 2 0 0 13 39 8 9 20 





207.9 CH 0 0 0 0 0 0 0 1 4 19 63 14 





59.6 CH 4 3 3 5 5 5 7 9 40 5 5 10 




1.6 CH 0 0 0 0 0 0 0 0 58 5 22 16 




2.1 CH 3 6 0 18 16 13 17 22 5 0 0 0 




0 CH 0 0 0 0 0 0 0 100 0 0 0 0 




2.9 CH 0 0 0 0 0 0 1 1 37 55 7 0 




18.3 CH 5 5 2 9 9 6 12 34 14 1 1 2 




7.5 CH 0 0 0 0 0 1 1 2 5 75 15 1 




1.5 CH 0 0 0 0 0 0 1 29 27 16 26 0 





61.6 CH 4 4 3 6 6 5 8 11 24 13 6 9 




4 CH 0 0 0 0 0 2 0 5 22 34 30 6 
1.5 IH 0 0 0 0 0 0 0 6 20 54 20 0 









23 CH 0 0 0 0 4 0 1 3 6 5 9 71 






60 CH 0 1 0 1 1 1 1 2 3 7 68 15 




1.9 CH 0 0 0 0 0 0 0 20 7 46 27 0 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




36 CH 0 0 0 1 0 0 1 2 2 4 81 8 




1.8 CH 0 0 0 0 0 0 0 0 6 0 76 19 




12.8 CH 3 2 1 6 4 2 3 9 8 22 37 4 




7.3 CH 1 0 0 3 5 2 2 5 5 7 62 8 




11.5 CH 0 0 0 0 0 0 2 4 2 18 57 17 




59.2 CH 2 2 1 2 4 0 1 4 5 5 69 5 




0.3 CH 0 0 0 0 0 0 0 0 0 0 0 100 





1.1 CH 0 0 0 0 0 0 0 1 0 0 13 86 





10.9 CH 0 0 0 0 3 2 0 3 6 5 23 58 





0 CH 0 0 0 0 0 0 0 0 0 0 0 0 




2.3 CH 0 0 0 0 0 0 0 0 0 0 0 100 




0.4 CH 0 0 0 0 0 0 0 0 0 0 0 100 





1.9 CH 0 0 0 0 0 0 0 0 0 0 18 82 
1.8 IH 0 0 0 0 0 0 0 0 0 0 34 66 
AGAP005432-PA 
Programmed cell 
death protein 5  
14.8 
1.3 CH 0 0 0 0 0 0 0 0 0 0 72 28 





0.2 CH 0 0 0 0 0 0 0 0 100 0 0 0 




35.6 CH 4 3 2 2 7 0 0 4 6 7 8 57 





39.4 CH 0 0 0 0 0 0 0 0 0 1 6 93 





7.2 CH 0 0 0 3 7 0 0 4 6 5 43 33 





13.9 CH 0 0 0 0 0 0 0 0 0 3 87 10 




0 CH 0 0 0 0 0 0 0 0 0 0 0 0 





47 CH 0 0 0 0 0 0 0 0 0 0 1 99 




0.6 CH 0 0 0 0 0 0 0 0 0 0 0 100 
0.5 IH 0 0 0 0 0 0 0 0 0 0 0 100 











3.3 CH 0 0 0 0 0 0 0 0 0 0 0 100 




0.5 CH 0 0 0 0 0 0 0 0 0 0 0 100 





44.3 CH 0 0 0 0 0 0 0 0 1 2 1 95 
52 IH 0 0 0 0 0 0 0 0 0 1 1 97 
*RA stands for relative abundance, it’s represented as [protein abundance * 10000/total protein abundance of CH or IH]. Molecular 
weight under each gel slice indicates the upper limit of each slice. The values of each protein in each slice is the percentage of 
abundance out of the protein’s total abundance in CH or IH, so 12 slices of each protein adds up to 100%. Red boxes indicate the 





PPO: Prophenoloxidase  RNAi: RNA interference CTL: c-type lectin 
PRR: pathogen recognition receptor PAMP: pathogen associated molecular pattern 
LPS: lipopolysaccharide LTA: lipoteichoic acid  IMD: immune deficiency 
PGRP: peptidoglycan recognition protein βGRP: β-1, 3-glucan recognition protein 
GNBP: Gram-negative bacteria binding protein  AMP: antimicrobial peptide 
PAP: PPO activating protease  SPH: serine protease homolog CH: control hemolymph 
HP: hemolymph protease DHI: 5, 6-dihydroxyindole MS: mass spectrometry 
LFQ: label-free quantification  PTU: 1-phenyl-2-thiourea IH: induced hemolymph 
PTGS: post-transcriptional gene silencing RISC: RNA inducing silencing complex 
qRT-PCR: quantitative reverse transcriptional PCR TBS: tris-buffered saline 
GAR-AP: alkaline phosphatase linked goat-anti-rabbit secondary antibody 
LDLp: low density lipophorin  TEP: thioester-containing protein FBN: fibrillin 
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